syndrome	score	normalized_score
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	1.0204082	100.0
CRI-DU-CHAT SYNDROME	1.01470468	99.441055060122
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0	97.99999647200012
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1.0	97.99999647200012
MIRAGE SYNDROME; MIRAGE	0.578018521	56.64581301875072
LOEYS-DIETZ SYNDROME 3; LDS3	0.5137064499999999	50.34323028764369
CHOPS SYNDROME; CHOPS	0.50819672	49.80327676708204
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.5	48.99999823600006
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.38500802	37.73078460169175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.3555552	34.844408345601295
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.3550721	34.79706454730567
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.35166819	34.463481379314665
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.347554101	34.060300671829175
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.334248751	32.756376418770444
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.333333	32.66663282400121
ALCOHOL SENSITIVITY, ACUTE	0.333333	32.66663282400121
ALDEHYDE DEHYDROGENASE 2 FAMILY	0.333333	32.66663282400121
CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF	0.333333	32.66663282400121
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.333333	32.66663282400121
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	32.66663282400121
PEROXISOME BIOGENESIS DISORDER 11B	0.24721329000000003	24.226901547831545
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.22670240000000003	22.216834400193964
DUBOWITZ SYNDROME	0.19954512	19.55542105600484
#615592 IMMUNODEFICIENCY 15; IMD15	0.197917	19.39586530174885
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	19.055540714000536
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	19.055540714000536
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	19.055540714000536
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	19.055540714000536
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	19.055540714000536
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	19.055540714000536
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	19.055540714000536
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.19165728999999998	18.7824137438331
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.18017410099999998	17.657061262345792
PHELAN-MCDERMID SYNDROME; PHMDS	0.17600086099999998	17.24808375706898
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17511509999999997	17.161279182193944
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.17407575099999997	17.059422983860767
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.17029019	16.688438019216232
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.169524501	16.61340049991758
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.16860875	16.52365690514835
IMMUNODEFICIENCY 15A; IMD15A	0.166667	16.333365411998845
KABUKI SYNDROME 1	0.15707810099999997	15.393653343828475
FONTAINE PROGEROID SYNDROME; FPS	0.15661865999999997	15.348628127449382
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.15424649999999998	15.116156455818363
GAUCHER DISEASE, TYPE II	0.14739594099999997	14.444801697987137
MARSHALL-SMITH SYNDROME; MRSHSS	0.14479874999999998	14.190276989150025
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.14377275099999998	14.089729090769747
GLYCEROL KINASE DEFICIENCY; GKD	0.14377275099999998	14.089729090769747
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.14285699999999998	13.99998549600052
OROFACIODIGITAL SYNDROME VIII; OFD8	0.14285699999999998	13.99998549600052
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.14285699999999998	13.99998549600052
OROFACIODIGITAL SYNDROME IX; OFD9	0.14285699999999998	13.99998549600052
BUERGER DISEASE	0.1338383	13.116152927818492
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.1338383	13.116152927818492
CLUSTER HEADACHE, FAMILIAL	0.1338383	13.116152927818492
BRUNNER SYNDROME; BRNRS	0.1328501	13.019309331304862
GLUTAMATE MONOSODIUM SENSITIVITY	0.1328501	13.019309331304862
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.12124947	11.882447632231884
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.11650715100000002	11.417700386962787
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.11473418999999999	11.243950215217788
RHEUMATOID ARTHRITIS	0.1147012	11.240717195334181
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.11305275	11.07916910114991
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	10.888877608000405
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.11111099999999999	10.888877608000405
PAROXYSMAL EXTREME PAIN DISORDER	0.11111099999999999	10.888877608000405
#615040 EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1	0.11111099999999999	10.888877608000405
FLUSHING OF EARS AND SOMNOLENCE	0.11111099999999999	10.888877608000405
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.11111099999999999	10.888877608000405
KERATOLYTIC WINTER ERYTHEMA; KWE	0.11111099999999999	10.888877608000405
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.11111099999999999	10.888877608000405
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.11111099999999999	10.888877608000405
BOOK SYNDROME	0.11111099999999999	10.888877608000405
PERICARDIAL EFFUSION, CHRONIC	0.11111099999999999	10.888877608000405
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	0.11111099999999999	10.888877608000405
PACHYONYCHIA CONGENITA 2	0.11111099999999999	10.888877608000405
%164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5;;ONYCHOLYSIS, PARTIAL, WITH SCLERONYCHIA;;ONYCHOLYSIS, HEREDITARY DISTAL	0.11111099999999999	10.888877608000405
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN	0.11111099999999999	10.888877608000405
DERMODISTORTIVE URTICARIA	0.11111099999999999	10.888877608000405
HYPERHIDROSIS PALMARIS ET PLANTARIS	0.11111099999999999	10.888877608000405
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.10819672000000001	10.603278178281986
Pontine tegmental cap dysplasia	0.10648069100000002	10.435107342336137
GM2-GANGLIOSIDOSIS, AB VARIANT	0.10091575100000001	9.889743241969244
TAY-SACHS DISEASE; TSD	0.10091575100000001	9.889743241969244
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.1	9.799999647200012
SPERMATOGENIC FAILURE 15; SPGF15	0.1	9.799999647200012
HYPEREKPLEXIA 1; HKPX1	0.1	9.799999647200012
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.1	9.799999647200012
CLEFT LARYNX, POSTERIORSTRIDOR, CONGENITAL, INCLUDED	0.1	9.799999647200012
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.1	9.799999647200012
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.08511982000000001	8.341742059697287
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08424905100000002	8.256406700769361
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08424905100000002	8.256406700769361
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.0839081	8.222993503972233
MYCOSIS FUNGOIDES	0.0839081	8.222993503972233
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.0839081	8.222993503972233
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	8.16666310600013
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.08146204100000001	7.9832797306019305
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0811279	7.950533913780779
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.07886485000000001	7.72875502176482
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.07783885100000001	7.628207123384543
#300867 KABUKI SYNDROME 2; KABUK2	0.07783885100000001	7.628207123384543
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.07783885100000001	7.628207123384543
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.07783885100000001	7.628207123384543
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.07783885100000001	7.628207123384543
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.07692310000000001	7.538463528615313
HYPOTONIA-CYSTINURIA SYNDROME	0.07692310000000001	7.538463528615313
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07692310000000001	7.538463528615313
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0761995	7.467550731168174
FASCIAL DYSTROPHY, CONGENITAL	0.07515820000000001	7.36550333484188
SANDHOFF DISEASE	0.0743855	7.289778737567964
PALLISTER-KILLIAN SYNDROME	0.072991651	7.153181540485464
CASPASE 8 DEFICIENCY	0.0707136	6.929932550522428
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.067582451	6.623079959569121
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	0.0666667	6.533336364799889
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.0666667	6.533336364799889
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0666667	6.533336364799889
PSORIASIS 14, PUSTULAR	0.0666667	6.533336364799889
LIG4 SYNDROME	0.0666667	6.533336364799889
PSORIASIS 2; PSORS2	0.0666667	6.533336364799889
PSORIASIS 1, SUSCEPTIBILITY TO	0.0666667	6.533336364799889
IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14	0.0666667	6.533336364799889
PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15	0.0666667	6.533336364799889
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.0666667	6.533336364799889
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0666667	6.533336364799889
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.0638865	6.260876774608436
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.0638865	6.260876774608436
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.0638865	6.260876774608436
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0638865	6.260876774608436
TUBEROUS SCLEROSIS	0.063415751	6.214743374269239
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.063415751	6.214743374269239
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.0625	6.1249997795000075
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.0625	6.1249997795000075
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.0625	6.1249997795000075
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0625	6.1249997795000075
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.0625	6.1249997795000075
HYDROXYKYNURENINURIA	0.0625	6.1249997795000075
PSEUDOTRISOMY 13 SYNDROME	0.0625	6.1249997795000075
LICHTENSTEIN SYNDROME	0.0625	6.1249997795000075
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0625	6.1249997795000075
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0625	6.1249997795000075
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0625	6.1249997795000075
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0625	6.1249997795000075
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.062346200000000004	6.109927380042614
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.062346200000000004	6.109927380042614
ROIFMAN SYNDROME; RFMN	0.0603769	5.916935986990303
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.05984215	5.864530488876901
MYXEDEMA	0.058907919999999996	5.772975952172865
NIJMEGEN BREAKAGE SYNDROME	0.0584416	5.7272765938180425
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.0579365	5.6777767956000345
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0579365	5.6777767956000345
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0579365	5.6777767956000345
611961 STEVENSON-CAREY SYNDROME	0.054965241000000005	5.386593424082637
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.05495879099999999	5.385961324105391
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.054582200000000004	5.349055407434005
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.053997199999999995	5.291725409497884
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.053997199999999995	5.291725409497884
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.0539773	5.289775209568092
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.0539773	5.289775209568092
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.0539773	5.289775209568092
#615207 IL21R IMMUNODEFICIENCY	0.0534722	5.240275411350084
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.0534722	5.240275411350084
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.0534722	5.240275411350084
IMMUNODEFICIENCY 50; IMD50	0.05295570000000001	5.189658413172298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.052573950999999994	5.152247012519107
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.05242215099999999	5.137370613054657
WILLIAMS-BEUREN SYNDROME; WBS	0.05210774	5.106558336163899
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.052042099999999994	5.100125616395477
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.052042099999999994	5.100125616395477
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.052042099999999994	5.100125616395477
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.052042099999999994	5.100125616395477
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.05133222	5.030557378899934
SHORT SYNDROME	0.050557710000000006	4.954655401632405
ERYTHERMALGIA, PRIMARY	0.049791919999999996	4.879607984334112
BAZEX SYNDROME; BZX	0.0490132	4.803293427081436
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.048491400000000004	4.752157028922347
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.048491400000000004	4.752157028922347
VESICOURETERAL REFLUX 8; VUR8	0.047077900000000006	4.613634033909174
OSTEOGENESIS IMPERFECTA, TYPE I	0.0469378	4.599904234403447
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.046335801	4.5409083345273
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.045832051	4.491540836304529
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.045011659999999995	4.411142521198869
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.0449495	4.40505084141817
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.044619149999999996	4.372676542583644
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.044394051000000004	4.350616841377794
COCKAYNE SYNDROME A; CSA	0.044394051000000004	4.350616841377794
SMITH-MAGENIS SYNDROME; SMS	0.044387521	4.349976901400831
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0442177	4.333334443999959
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.044051251	4.3170224425871915
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0439613	4.308207244904539
UROFACIAL SYNDROME	0.04391102	4.303279805081927
UROFACIAL SYNDROME 2	0.04391102	4.303279805081927
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.043478300000000004	4.260873246608563
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.043478300000000004	4.260873246608563
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.043478300000000004	4.260873246608563
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.043478300000000004	4.260873246608563
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.043478300000000004	4.260873246608563
VAN DEN BOSCH SYNDROME	0.043478300000000004	4.260873246608563
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.043478300000000004	4.260873246608563
ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD	0.043478300000000004	4.260873246608563
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.043478300000000004	4.260873246608563
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.043478300000000004	4.260873246608563
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.04308679	4.22250526798981
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.0430147	4.215440448244144
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.042283601	4.1437927488234605
MARSILI SYNDROME; MARSIS	0.0421473	4.1304352513043305
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0421473	4.1304352513043305
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.041196261000000005	4.037233432659597
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.040884451	4.006676053759662
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.040816399999999996	4.000007055999745
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.040280510000000005	3.947489837890366
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.040280510000000005	3.947489837890366
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.039924441000000005	3.912595077146577
BRITTLE CORNEA SYNDROME 2; BCS2	0.03973931	3.8944522397997194
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.0394636	3.8674326607724243
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.0394636	3.8674326607724243
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0394636	3.8674326607724243
GITELMAN SYNDROME	0.039415470999999994	3.8627160189422223
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.039325201	3.8538695592606955
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.03912074	3.8338323819820337
EHLERS-DANLOS SYNDROME, TYPE VI	0.03905821	3.8277044422026405
ADIPOSIS DOLOROSA	0.038499719999999994	3.772972424172992
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.038347730999999996	3.758077502709209
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.038118571000000004	3.7356198235176863
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.037740061	3.6985258448530693
CHROMOSOME 17q12 DELETION SYNDROME	0.03765605	3.6902927671494603
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.03765605	3.6902927671494603
TEMPLE SYNDROME	0.03733674	3.6590003882759854
AICARDI SYNDROME; AIC	0.03732725	3.6580703683094664
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.03711485	3.6372551690588133
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.03695649	3.621735889617508
NOONAN SYNDROME 7; NS7	0.036948401	3.620943167646046
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.03673911	3.600432650384424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.036731961	3.5997320484096456
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.036467700000000006	3.5738344713419594
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.036416511	3.5688179495225536
HALLERMANN-STREIFF SYNDROME; HSS	0.03603265	3.531199572876815
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.036028631	3.530805710890994
CORNELIA DE LANGE SYNDROME 1	0.035900881	3.5182862113416964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.035788941	3.5073160917366204
SECKEL SYNDROME 9; SCKL9	0.035714300000000004	3.5000012739999544
JOUBERT SYNDROME 35; JBTS35	0.035714300000000004	3.5000012739999544
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.035714300000000004	3.5000012739999544
#610984 COMPLEMENT FACTOR I DEFICIENCY; CFID;;COMPLEMENT COMPONENT 3 INACTIVATOR DEFICIENCY;;C3 INACTIVATOR DEFICIENCY	0.035714300000000004	3.5000012739999544
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.035714300000000004	3.5000012739999544
BARE LYMPHOCYTE SYNDROME, TYPE II	0.035714300000000004	3.5000012739999544
109820 BLADDER DIVERTICULUM	0.035714300000000004	3.5000012739999544
EVEN-PLUS SYNDROME	0.035714300000000004	3.5000012739999544
CURRARINO SYNDROME	0.035714300000000004	3.5000012739999544
HARDIKAR SYNDROME	0.035714300000000004	3.5000012739999544
POLYCYSTIC KIDNEY DISEASE 2	0.035714300000000004	3.5000012739999544
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.035313051	3.4606788734155605
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03527505	3.456954775549628
OSTEOGENESIS IMPERFECTA, TYPE V	0.0351731	3.446963675909307
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0351731	3.446963675909307
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.03486921	3.417182456981431
SENGERS SYNDROME	0.03486921	3.417182456981431
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.034547209999999995	3.3856264581174464
MEIER-GORLIN SYNDROME 3; MGORS3	0.034547209999999995	3.3856264581174464
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.034249051	3.3564068771693525
CRANIOECTODERMAL DYSPLASIA 4	0.0340909	3.340908079727309
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.033926189999999995	3.324766500308405
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.033926189999999995	3.324766500308405
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	3.2666632824001214
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	3.2666632824001214
NAVAJO NEUROHEPATOPATHY	0.0333333	3.2666632824001214
MYELOPEROXIDASE DEFICIENCY	0.0333333	3.2666632824001214
ECHO VIRUS 11 SENSITIVITY	0.0333333	3.2666632824001214
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	3.2666632824001214
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	3.2666632824001214
BLOOD GROUP, DUFFY SYSTEM; FY	0.0333333	3.2666632824001214
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0333333	3.2666632824001214
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	3.2666632824001214
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	3.2666632824001214
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0333333	3.2666632824001214
IMMUNE SUPPRESSION	0.0333333	3.2666632824001214
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	3.2666632824001214
TRICHOHEPATOENTERIC SYNDROME 1	0.0333333	3.2666632824001214
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	3.2666632824001214
MYASTHENIA GRAVIS; MG	0.0333333	3.2666632824001214
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.0333333	3.2666632824001214
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	3.2666632824001214
RAGWEED SENSITIVITY	0.0333333	3.2666632824001214
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	3.2666632824001214
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	3.2666632824001214
Growth hormone deficiency, isolated, type IA	0.0333333	3.2666632824001214
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	3.2666632824001214
TENORIO SYNDROME; TNORS	0.033276421	3.2610891406007902
CYCLIC VOMITING SYNDROME	0.033173851	3.251037280962657
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.033173851	3.251037280962657
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.033173851	3.251037280962657
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.033173851	3.251037280962657
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.033173851	3.251037280962657
EPISODIC ATAXIA, TYPE 6	0.033173851	3.251037280962657
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.033173851	3.251037280962657
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.033173851	3.251037280962657
PHACE ASSOCIATION	0.033173851	3.251037280962657
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.033173851	3.251037280962657
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.033173851	3.251037280962657
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.03317121	3.2507784629719745
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.032793321	3.213745342305167
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.0322581	3.1612936861934267
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.0322581	3.1612936861934267
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.0322581	3.1612936861934267
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.0322581	3.1612936861934267
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.0322581	3.1612936861934267
PEROXISOME BIOGENESIS DISORDER 14B	0.0322581	3.1612936861934267
STORMORKEN SYNDROME; STRMK	0.0322581	3.1612936861934267
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0322581	3.1612936861934267
EPISODIC ATAXIA, TYPE 2	0.0322581	3.1612936861934267
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0322581	3.1612936861934267
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0322581	3.1612936861934267
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.0322581	3.1612936861934267
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0322581	3.1612936861934267
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0321729	3.1529440864940126
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.032165751	3.152243484519234
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.03200622	3.1366094470820594
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0315261	3.089557688775923
KOOLEN-DE VRIES SYNDROME; KDVS	0.031462501000000004	3.0833249870003003
CONGENITAL SHORT BOWEL SYNDROME	0.03125	3.0624998897500038
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.03125	3.0624998897500038
IMMUNODEFICIENCY 36; IMD36	0.03125	3.0624998897500038
IMMUNODEFICIENCY 46; IMD46	0.03125	3.0624998897500038
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.03125	3.0624998897500038
#613291 BILE ACID MALABSORPTION, PRIMARY; PBAM	0.03125	3.0624998897500038
Trichothiodystrophy 5, nonphotosensitive	0.03125	3.0624998897500038
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.03125	3.0624998897500038
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.03125	3.0624998897500038
#614699 IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7	0.03125	3.0624998897500038
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.03125	3.0624998897500038
RADICULONEUROPATHY, FATAL NEONATAL	0.03125	3.0624998897500038
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.031218750999999996	3.0594374878602495
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.031218750999999996	3.0594374878602495
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.030924019999999997	3.030553850900061
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.030924019999999997	3.030553850900061
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.030851571	3.0234538491556613
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.030614540999999995	3.0002249099919025
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.030302999999999997	2.9696938930910193
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.030302999999999997	2.9696938930910193
BARTH SYNDROME; BTHS	0.030302999999999997	2.9696938930910193
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.030302999999999997	2.9696938930910193
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.030302999999999997	2.9696938930910193
#616000 ANALBUMINEMIA; ANALBA	0.030302999999999997	2.9696938930910193
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.030302999999999997	2.9696938930910193
HEMOCHROMATOSIS, TYPE 3; HFE3	0.030302999999999997	2.9696938930910193
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.030302999999999997	2.9696938930910193
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.030302999999999997	2.9696938930910193
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.030302999999999997	2.9696938930910193
HEMOCHROMATOSIS, TYPE 4; HFE4	0.030302999999999997	2.9696938930910193
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.030302999999999997	2.9696938930910193
ANISOCORIA	0.030302999999999997	2.9696938930910193
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.030302999999999997	2.9696938930910193
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.030302999999999997	2.9696938930910193
SATOYOSHI SYNDROME	0.030302999999999997	2.9696938930910193
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.030302999999999997	2.9696938930910193
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.030302999999999997	2.9696938930910193
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.029935820000000002	2.9337102543864306
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.029899600000000002	2.930160694514215
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.029520671	2.893025653851076
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.029520671	2.893025653851076
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029520671	2.893025653851076
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.02923526	2.865055376858006
THROMBOCYTOPENIA 1	0.0290061	2.842597697666483
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.02860492	2.8032820590818455
SCHAAF-YANG SYNDROME; SHFYNG	0.027440341	2.68915332119048
EMANUEL SYNDROME	0.027440341	2.68915332119048
CRANIOSYNOSTOSIS 2	0.027221061	2.6676638819641
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.02646938	2.5939991466160306
PROPIONIC ACIDEMIA	0.026353871	2.5826792650235464
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.026350489999999997	2.582347927035474
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.02606828	2.554691348031111
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.026041010999999996	2.5520189861273157
MARFANOID HYPERMOBILITY SYNDROME	0.025963550000000002	2.5444278084005987
LATERAL MENINGOCELE SYNDROME	0.025963550000000002	2.5444278084005987
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02575125	2.523622409149593
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.02575125	2.523622409149593
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.02575125	2.523622409149593
COLE-CARPENTER SYNDROME 1; CLCRP1	0.02575125	2.523622409149593
OSTEOGENESIS IMPERFECTA, TYPE IV	0.02575125	2.523622409149593
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.02575125	2.523622409149593
Osteogenesis imperfecta, type IX	0.02575125	2.523622409149593
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.02575125	2.523622409149593
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.02575125	2.523622409149593
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.025584800999999997	2.507310407736825
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.025125259999999996	2.4622753913580855
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.025070050000000003	2.456864811552867
MACS SYNDROME	0.025070050000000003	2.456864811552867
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.024947141	2.4448197299864893
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.024725251	2.4230745107693177
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.024725251	2.4230745107693177
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.024725251	2.4230745107693177
Ullrich congenital muscular dystrophy 1	0.024669049999999998	2.4175668129675945
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.024669049999999998	2.4175668129675945
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.024669049999999998	2.4175668129675945
ALSTROM SYNDROME; ALMS	0.024669049999999998	2.4175668129675945
WHITE-SUTTON SYNDROME; WHSUS	0.02458284	2.4091182332717436
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.02416395	2.3680670147495873
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.02403139	2.355076135217259
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.02403139	2.355076135217259
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.02403139	2.355076135217259
TYSHCHENKO SYNDROME	0.02403139	2.355076135217259
CHROMOSOME 1P36 DELETION SYNDROME	0.023817151	2.3340807139730946
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.0238095	2.333330916000087
GRANGE SYNDROME; GRNG	0.0238095	2.333330916000087
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.0238095	2.333330916000087
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.0238095	2.333330916000087
GERODERMA OSTEODYSPLASTICUM; GO	0.0238095	2.333330916000087
#133780 EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROMERETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED	0.0238095	2.333330916000087
PAGET DISEASE OF BONE 6	0.0238095	2.333330916000087
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0238095	2.333330916000087
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.0238095	2.333330916000087
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.0238095	2.333330916000087
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0238095	2.333330916000087
HYPOPHOSPHATASIA, ADULT	0.0238095	2.333330916000087
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0238095	2.333330916000087
DENT DISEASE 1	0.0238095	2.333330916000087
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.0238095	2.333330916000087
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.0238095	2.333330916000087
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0238095	2.333330916000087
OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES	0.0238095	2.333330916000087
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0238095	2.333330916000087
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.023722091	2.324764834308466
CAMURATI-ENGELMANN DISEASE	0.02368085	2.320723216453964
CHIARI MALFORMATION TYPE I	0.02368085	2.320723216453964
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.023643050999999998	2.317018914587319
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.023265701	2.2800386159186097
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.023265701	2.2800386159186097
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.02318351	2.271983898208579
MEIER-GORLIN SYNDROME 2; MGORS2	0.02318351	2.271983898208579
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.023183509999999997	2.271983898208579
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.023137951	2.2675191163693116
TIMOTHY SYNDROME; TS	0.023137951	2.2675191163693116
LOEYS-DIETZ SYNDROME 5	0.023128300000000004	2.2665733184033607
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.023128300000000004	2.2665733184033607
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.023128300000000004	2.2665733184033607
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.022874131	2.241664757300068
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.022874131	2.241664757300068
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.022874131	2.241664757300068
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0227273	2.227275319818088
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.0227273	2.227275319818088
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0227273	2.227275319818088
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0227273	2.227275319818088
#612692 AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT	0.0227273	2.227275319818088
GRANULOSIS RUBRA NASI	0.0227273	2.227275319818088
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0227273	2.227275319818088
STIFF-PERSON SYNDROME; SPS	0.0227273	2.227275319818088
#614594 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTICPLAQUES;;OLMSTED SYNDROME; OLMS	0.0227273	2.227275319818088
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.0227273	2.227275319818088
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.0227273	2.227275319818088
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.0227273	2.227275319818088
PARAGANGLIOMAS 3	0.0227273	2.227275319818088
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.0227273	2.227275319818088
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0227273	2.227275319818088
#615726 PACHYONYCHIA CONGENITA 3; PC3	0.0227273	2.227275319818088
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.0227273	2.227275319818088
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0227273	2.227275319818088
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	2.227275319818088
MAL DE MELEDA	0.0227273	2.227275319818088
CYSTIC FIBROSIS	0.0227273	2.227275319818088
#613500 AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGLL1 DEFECT	0.0227273	2.227275319818088
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0227273	2.227275319818088
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.0227273	2.227275319818088
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.0227273	2.227275319818088
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0227273	2.227275319818088
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0227273	2.227275319818088
TRIMETHYLAMINURIA	0.0227273	2.227275319818088
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0227273	2.227275319818088
CILIARY DYSKINESIA, PRIMARY, 33	0.0227273	2.227275319818088
ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	0.0227273	2.227275319818088
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.0227273	2.227275319818088
#613494 IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4;;ANTIBODY DEFICIENCY DUE TO BAFFR DEFECT	0.0227273	2.227275319818088
TRACHEOPATHIA OSTEOPLASTICA	0.0227273	2.227275319818088
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.0227273	2.227275319818088
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0227273	2.227275319818088
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.0227273	2.227275319818088
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0227273	2.227275319818088
#601495 AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT	0.0227273	2.227275319818088
PARAGANGLIOMAS 1	0.0227273	2.227275319818088
ROWLEY-ROSENBERG SYNDROME	0.0227273	2.227275319818088
PARAGANGLIOMAS 4	0.0227273	2.227275319818088
#170100 PROLIDASE DEFICIENCY	0.0227273	2.227275319818088
HYPERHIDROSIS, GUSTATORY	0.0227273	2.227275319818088
#613502 AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO BLNK DEFECT	0.0227273	2.227275319818088
PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	0.0227273	2.227275319818088
PHEOCHROMOCYTOMA	0.0227273	2.227275319818088
MASP2 DEFICIENCY	0.0227273	2.227275319818088
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0227273	2.227275319818088
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.0227273	2.227275319818088
PARIETAL FORAMINA	0.022654851	2.2201753180736885
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.022654851	2.2201753180736885
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.022654851	2.2201753180736885
NEUROFIBROMATOSIS, TYPE II	0.022654851	2.2201753180736885
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.022654851	2.2201753180736885
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.022654851	2.2201753180736885
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.022654851	2.2201753180736885
PAPILLOMA OF CHOROID PLEXUS	0.022654851	2.2201753180736885
SNEDDON SYNDROME	0.022654851	2.2201753180736885
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.022417820999999997	2.1969463789099297
LOWE OCULOCEREBRORENAL SYNDROME	0.022417820999999997	2.1969463789099297
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.022349949999999997	2.190295021149379
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.022349949999999997	2.190295021149379
#312863 COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX;;XCID;;IMMUNODEFICIENCY 6; IMD6	0.0222222	2.177775521600081
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.0222222	2.177775521600081
ROIFMAN-CHITAYAT SYNDROME	0.0222222	2.177775521600081
#615206 CARD11 IMMUNODEFICIENCY	0.0222222	2.177775521600081
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0222222	2.177775521600081
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.0222222	2.177775521600081
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0222222	2.177775521600081
215030 CHOLESTEROL PNEUMONIA	0.0222222	2.177775521600081
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0222222	2.177775521600081
#269840 SELECTIVE T-CELL DEFECT; STCD	0.0222222	2.177775521600081
#615561 COMPLEMENT FACTOR B DEFICIENCY; CFBD	0.0222222	2.177775521600081
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.0222222	2.177775521600081
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0222222	2.177775521600081
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.0222222	2.177775521600081
IMMUNODEFICIENCY 32B; IMD32B	0.0222222	2.177775521600081
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.0222222	2.177775521600081
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0222222	2.177775521600081
#600802 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,B CELL-POSITIVE, NK CELL-NEGATIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	0.0222222	2.177775521600081
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0222222	2.177775521600081
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0222222	2.177775521600081
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.0222222	2.177775521600081
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.0222222	2.177775521600081
IMMUNODEFICIENCY 13; IMD13	0.0222222	2.177775521600081
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0222222	2.177775521600081
MUSCULAR HYPERTONIA, LETHAL	0.0222222	2.177775521600081
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.02195838	2.151921162530838
PITT-HOPKINS SYNDROME	0.021875401	2.143789220823588
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.02180761	2.1371457030627545
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.021770671	2.1335256811930754
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0217391	2.130431723304458
HYPER-IGD SYNDROME	0.0217391	2.130431723304458
EPISODIC ATAXIA, TYPE 3	0.0217391	2.130431723304458
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.0217391	2.130431723304458
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0217391	2.130431723304458
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0217391	2.130431723304458
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.0217391	2.130431723304458
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0217391	2.130431723304458
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0217391	2.130431723304458
EPISODIC ATAXIA, TYPE 1; EA1	0.0217391	2.130431723304458
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0217391	2.130431723304458
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.0217391	2.130431723304458
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0217391	2.130431723304458
SCLEROSTEOSIS 1; SOST1	0.0217391	2.130431723304458
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0217391	2.130431723304458
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0217391	2.130431723304458
Polyarteritis nodosa, childhood-onset	0.0217391	2.130431723304458
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.021502069999999998	2.107202784140699
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.021323950999999997	2.089747122769103
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.021323950999999997	2.089747122769103
INFANTILE SIALIC ACID STORAGE DISEASE	0.021323950999999997	2.089747122769103
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	2.089747122769103
KAGAMI-OGATA SYNDROME	0.021323950999999997	2.089747122769103
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.021323950999999997	2.089747122769103
Fabry disease	0.021323950999999997	2.089747122769103
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.021323950999999997	2.089747122769103
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.021323950999999997	2.089747122769103
GAUCHER DISEASE, PERINATAL LETHAL	0.021323950999999997	2.089747122769103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.020932381	2.051373264150562
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.020932381	2.051373264150562
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.020864590000000002	2.0447297463897294
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02080965	2.0393456265835574
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02080965	2.0393456265835574
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.020476071	2.006654885760424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	2.0000035279998727
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	2.0000035279998727
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.020408199999999998	2.0000035279998727
#161000 NAEGELI SYNDROME;;NAEGELI-FRANCESCHETTI-JADASSOHN SYNDROME;;NFJ SYNDROME; NFJS	0.020408199999999998	2.0000035279998727
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	2.0000035279998727
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	2.0000035279998727
Diamond-Blackfan anemia 1	0.020408199999999998	2.0000035279998727
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.020408199999999998	2.0000035279998727
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.020408199999999998	2.0000035279998727
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.020408199999999998	2.0000035279998727
IMMUNODEFICIENCY 10; IMD10	0.020408199999999998	2.0000035279998727
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	2.0000035279998727
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	2.0000035279998727
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.020408199999999998	2.0000035279998727
NEMALINE MYOPATHY 10	0.020408199999999998	2.0000035279998727
#615328 SHAHEEN SYNDROME; SHNS	0.020408199999999998	2.0000035279998727
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	2.0000035279998727
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.020408199999999998	2.0000035279998727
#129490 ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT;ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	0.020408199999999998	2.0000035279998727
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	0.020408199999999998	2.0000035279998727
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.020408199999999998	2.0000035279998727
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.020408199999999998	2.0000035279998727
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	2.0000035279998727
ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12	0.020408199999999998	2.0000035279998727
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	2.0000035279998727
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	2.0000035279998727
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.020408199999999998	2.0000035279998727
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	2.0000035279998727
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.020408199999999998	2.0000035279998727
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	2.0000035279998727
COSTELLO SYNDROME; CSTLO	0.020408199999999998	2.0000035279998727
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	2.0000035279998727
FRONTONASAL DYSPLASIA 2; FND2	0.020408199999999998	2.0000035279998727
HELIX SYNDROME; HELIX	0.020408199999999998	2.0000035279998727
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	0.020408199999999998	2.0000035279998727
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	2.0000035279998727
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	2.0000035279998727
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.020408199999999998	2.0000035279998727
CYSTINOSIS, NEPHROPATHIC; CTNS	0.020408199999999998	2.0000035279998727
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.020408199999999998	2.0000035279998727
#603543 LIMB-MAMMARY SYNDROME; LMS	0.020408199999999998	2.0000035279998727
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	2.0000035279998727
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	2.0000035279998727
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.020408199999999998	2.0000035279998727
ROSSELLI-GULIENETTI SYNDROME	0.020408199999999998	2.0000035279998727
YUNIS-VARON SYNDROME	0.020408199999999998	2.0000035279998727
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.020408199999999998	2.0000035279998727
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	2.0000035279998727
COFFIN-SIRIS SYNDROME 8; CSS8	0.020098901	1.9696922270910795
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.020098901	1.9696922270910795
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.02001663	1.9616296693813318
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.02001663	1.9616296693813318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.02001663	1.9616296693813318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.02001663	1.9616296693813318
RETT SYNDROME; RTT	0.019250941	1.8865921500826826
RETT SYNDROME, CONGENITAL VARIANT	0.019250941	1.8865921500826826
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.019250941	1.8865921500826826
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.019243621	1.8858747901085073
IMMUNODEFICIENCY 23; IMD23	0.01918315	1.879948632321849
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.01918315	1.879948632321849
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.849054133434051
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.849054133434051
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.849054133434051
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.849054133434051
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.849054133434051
MYOPATHY, CONGENITAL	0.0188679	1.849054133434051
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.849054133434051
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.849054133434051
PALMOMENTAL REFLEX	0.0188679	1.849054133434051
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.849054133434051
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.849054133434051
DIASTEMATOMYELIA	0.0188679	1.849054133434051
JUMPING FRENCHMAN OF MAINE	0.0188679	1.849054133434051
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.849054133434051
THUMBS, CONGENITAL CLASPED	0.0188679	1.849054133434051
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.849054133434051
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.849054133434051
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.849054133434051
CARDIAC ARRHYTHMIA	0.0188679	1.849054133434051
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.849054133434051
CERVICAL RIB	0.0188679	1.849054133434051
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.849054133434051
269800 SENILE PLAQUE FORMATION	0.0188679	1.849054133434051
ALCOHOL DEPENDENCE	0.0188679	1.849054133434051
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.849054133434051
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.849054133434051
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.849054133434051
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.849054133434051
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.849054133434051
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.849054133434051
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.849054133434051
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.849054133434051
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.849054133434051
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.849054133434051
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.849054133434051
TRANSSEXUALITY	0.0188679	1.849054133434051
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.849054133434051
MOTION SICKNESS	0.0188679	1.849054133434051
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.849054133434051
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.849054133434051
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.849054133434051
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.849054133434051
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.849054133434051
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.849054133434051
JABERI-ELAHI SYNDROME; JABELS	0.018787311	1.8411564117183692
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.018787311	1.8411564117183692
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.018787311	1.8411564117183692
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.018272660000000003	1.7907206155340578
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.018157151	1.7794007339415732
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.018157151	1.7794007339415732
PHENYLKETONURIA	0.018157151	1.7794007339415732
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.018157151	1.7794007339415732
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.018157151	1.7794007339415732
SULFOCYSTEINURIA	0.018157151	1.7794007339415732
CHROMOSOME 2q37 DELETION SYNDROME	0.018157151	1.7794007339415732
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.01787156	1.7514128169491388
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.01787156	1.7514128169491388
ZTTK SYNDROME; ZTTKS	0.017844291	1.7487404550453438
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.017309190999999998	1.6963006569331762
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.017309190999999998	1.6963006569331762
Xq28 (MECP2) duplication	0.017309190999999998	1.6963006569331762
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.017309190999999998	1.6963006569331762
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.017309190999999998	1.6963006569331762
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.017309190999999998	1.6963006569331762
BOHRING-OPITZ SYNDROME	0.017301871	1.6955832969590012
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.017301871	1.6955832969590012
DESANTO-SHINAWI SYNDROME	0.017301871	1.6955832969590012
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.0172414	1.6896571391723427
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0172414	1.6896571391723427
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0172414	1.6896571391723427
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0172414	1.6896571391723427
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0172414	1.6896571391723427
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0172414	1.6896571391723427
BLAU SYNDROME	0.0172414	1.6896571391723427
DERMATITIS, ATOPIC	0.0172414	1.6896571391723427
NEUTROPHIL CHEMOTACTIC RESPONSE	0.0172414	1.6896571391723427
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.0172414	1.6896571391723427
IMMUNODEFICIENCY 55; IMD55	0.0172414	1.6896571391723427
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0172414	1.6896571391723427
PELGER-HUET ANOMALY; PHA	0.0172414	1.6896571391723427
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0172414	1.6896571391723427
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0172414	1.6896571391723427
IGE RESPONSIVENESS, ATOPIC	0.0172414	1.6896571391723427
PORPHYRIA CUTANEA TARDA, TYPE I	0.0172414	1.6896571391723427
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0172414	1.6896571391723427
#615607 IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	0.0172414	1.6896571391723427
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.0172414	1.6896571391723427
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.016928540000000002	1.658996860276113
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.016928540000000002	1.658996860276113
COHEN SYNDROME	0.016845561000000002	1.6508649185688629
COFFIN-SIRIS SYNDROME 6; CSS6	0.01639344	1.6065570621639456
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.01639344	1.6065570621639456
EHLERS-DANLOS SYNDROME, TYPE I	0.01633091	1.6004291223845515
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.01633091	1.6004291223845515
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.01633091	1.6004291223845515
MARFAN SYNDROME; MFS	0.015929810000000003	1.5611213237996324
STICKLER SYNDROME, TYPE II	0.015929810000000003	1.5611213237996324
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.015902541000000003	1.5584489618958375
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.015902541000000003	1.5584489618958375
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.015902541000000003	1.5584489618958375
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.015620431	1.5308021828911214
ANGELMAN SYNDROME	0.015620431	1.5308021828911214
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.014986790000000002	1.4687053671266068
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.014677411	1.4383862262180958
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.014677410999999998	1.4383862262180955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.014677410999999998	1.4383862262180955
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.014677410999999998	1.4383862262180955
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.014677410999999998	1.4383862262180955
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.01459995	1.430795048491378
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01459995	1.430795048491378
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014221101	1.3936678478279574
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.014221101	1.3936678478279574
GAPO SYNDROME; GAPOS	0.014221101	1.3936678478279574
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.013761659999999998	1.3486426314488649
POPOV-CHANG SYNDROME; POPCHAS	0.013761659999999998	1.3486426314488649
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.013761659999999998	1.3486426314488649
BAKER-GORDON SYNDROME; BAGOS	0.013761659999999998	1.3486426314488649
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.013761659999999998	1.3486426314488649
AU-KLINE SYNDROME; AUKS	0.013761659999999998	1.3486426314488649
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.013706450000000002	1.3432320516436462
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.013706450000000002	1.3432320516436462
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.013706450000000002	1.3432320516436462
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.013706450000000002	1.3432320516436462
BRANCHIOOCULOFACIAL SYNDROME	0.013678680999999998	1.3405106897416148
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.013678680999999998	1.3405106897416148
CORNELIA DE LANGE SYNDROME 3	0.013678680999999998	1.3405106897416148
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.013573951	1.3302471501111026
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.013573951	1.3302471501111026
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.013573951	1.3302471501111026
ODONTOCHONDRODYSPLASIA; ODCD	0.01330535	1.3039242530587267
#278250 WRINKLY SKIN SYNDROME; WSS	0.01330535	1.3039242530587267
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.01330535	1.3039242530587267
CARTILAGE-HAIR HYPOPLASIA; CHH	0.01330535	1.3039242530587267
15q26 overgrowth syndrome	0.01330535	1.3039242530587267
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012762929999999999	1.2507670949723844
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.012762929999999999	1.2507670949723844
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.012735660999999999	1.2480947330685894
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.012735660999999999	1.2480947330685894
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.012735660999999999	1.2480947330685894
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.012735660999999999	1.2480947330685894
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.012735660999999999	1.2480947330685894
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.012735660999999999	1.2480947330685894
CHROMOSOME 19p13.13 DELETION SYNDROME	0.012735660999999999	1.2480947330685894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.012735660999999999	1.2480947330685894
MENTAL RETARDATION, X-LINKED 98; MRX98	0.012735660999999999	1.2480947330685894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012735660999999999	1.2480947330685894
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.012735660999999999	1.2480947330685894
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.012680451	1.2426841532633703
LENTIGINES	0.012658200000000001	1.240503555341872
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.012658200000000001	1.240503555341872
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.012658200000000001	1.240503555341872
#300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN	0.012658200000000001	1.240503555341872
GLOMUVENOUS MALFORMATIONS	0.012658200000000001	1.240503555341872
TYROSINE TRANSAMINASE DEFICIENCY	0.012658200000000001	1.240503555341872
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.012658200000000001	1.240503555341872
CURRY-JONES SYNDROME	0.012658200000000001	1.240503555341872
PERIODONTITIS, AGGRESSIVE, 1	0.012658200000000001	1.240503555341872
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.012658200000000001	1.240503555341872
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.012658200000000001	1.240503555341872
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.012658200000000001	1.240503555341872
INSECT STINGS, HYPERSENSITIVITY TO	0.012658200000000001	1.240503555341872
TRICHILEMMAL CYST 1	0.012658200000000001	1.240503555341872
PIGMENTED PURPURIC ERUPTION	0.012658200000000001	1.240503555341872
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.012658200000000001	1.240503555341872
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.012658200000000001	1.240503555341872
MUCOPOLYSACCHARIDOSIS TYPE IX	0.012658200000000001	1.240503555341872
SIMOSA CRANIOFACIAL SYNDROME	0.012658200000000001	1.240503555341872
KERATOSIS, FAMILIAL ACTINIC	0.012658200000000001	1.240503555341872
DERMATOSIS PAPULOSA NIGRA	0.012658200000000001	1.240503555341872
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.012658200000000001	1.240503555341872
CIRCUMVALLATE PLACENTA SYNDROME	0.012658200000000001	1.240503555341872
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.012658200000000001	1.240503555341872
COMEDONES, FAMILIAL DYSKERATOTIC	0.012658200000000001	1.240503555341872
PATELLA APLASIA-HYPOPLASIA	0.012658200000000001	1.240503555341872
#162091 SCHWANNOMATOSIS;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS	0.012658200000000001	1.240503555341872
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.012658200000000001	1.240503555341872
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.012658200000000001	1.240503555341872
SPINOCEREBELLAR ATAXIA 34; SCA34	0.012658200000000001	1.240503555341872
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.012658200000000001	1.240503555341872
131600 EPIDERMOID CYSTS	0.012658200000000001	1.240503555341872
LICHEN PLANUS, FAMILIAL	0.012658200000000001	1.240503555341872
SYRINGOMAS, MULTIPLE	0.012658200000000001	1.240503555341872
SAY SYNDROME	0.012658200000000001	1.240503555341872
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.012658200000000001	1.240503555341872
KYRLE DISEASE	0.012658200000000001	1.240503555341872
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.012658200000000001	1.240503555341872
ACROMIAL DIMPLES	0.012658200000000001	1.240503555341872
CAROTENEMIA, FAMILIAL	0.012658200000000001	1.240503555341872
PARANA HARD-SKIN SYNDROME	0.012658200000000001	1.240503555341872
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.012658200000000001	1.240503555341872
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.012658200000000001	1.240503555341872
PSEUDOATROPHODERMA COLLI	0.012658200000000001	1.240503555341872
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.012658200000000001	1.240503555341872
CALLOSITIES, HEREDITARY PAINFUL	0.012658200000000001	1.240503555341872
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.012658200000000001	1.240503555341872
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.012658200000000001	1.240503555341872
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.012658200000000001	1.240503555341872
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.012658200000000001	1.240503555341872
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.012658200000000001	1.240503555341872
PILONIDAL SINUS	0.012658200000000001	1.240503555341872
PRENATAL BOWING	0.012658200000000001	1.240503555341872
FUTCHER LINE	0.012658200000000001	1.240503555341872
DERMAL RIDGES, PATTERNLESS	0.012658200000000001	1.240503555341872
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.012658200000000001	1.240503555341872
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.012658200000000001	1.240503555341872
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.012658200000000001	1.240503555341872
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.012658200000000001	1.240503555341872
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.012658200000000001	1.240503555341872
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.012658200000000001	1.240503555341872
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.012279351	1.203376354678451
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.012279351	1.203376354678451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.012279351	1.203376354678451
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.012279351	1.203376354678451
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.012279351	1.203376354678451
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.01181991	1.1583511382993588
COFFIN-SIRIS SYNDROME 7; CSS7	0.01181991	1.1583511382993588
MEIER-GORLIN SYNDROME 5; MGORS5	0.01181991	1.1583511382993588
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.01181991	1.1583511382993588
MEIER-GORLIN SYNDROME 6; MGORS6	0.01181991	1.1583511382993588
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.01181991	1.1583511382993588
Congenital prothrombin deficiency	0.011764700000000001	1.15294055849414
#614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7	0.011764700000000001	1.15294055849414
ARTERIAL TORTUOSITY SYNDROME	0.011764700000000001	1.15294055849414
BLEEDING DISORDER, PLATELET-TYPE, 20	0.011764700000000001	1.15294055849414
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.011764700000000001	1.15294055849414
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.011764700000000001	1.15294055849414
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.011764700000000001	1.15294055849414
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.011764700000000001	1.15294055849414
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.011764700000000001	1.15294055849414
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.011764700000000001	1.15294055849414
FECHTNER SYNDROME	0.011764700000000001	1.15294055849414
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.011764700000000001	1.15294055849414
FACTOR XIII, B SUBUNIT, DEFICIENCY OF	0.011764700000000001	1.15294055849414
HEMOPHILIA A	0.011764700000000001	1.15294055849414
Glanzmann thrombasthenia	0.011764700000000001	1.15294055849414
168830 PASSOVOY FACTOR DEFECT	0.011764700000000001	1.15294055849414
FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	0.011764700000000001	1.15294055849414
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.011764700000000001	1.15294055849414
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.011764700000000001	1.15294055849414
BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	0.011764700000000001	1.15294055849414
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.011764700000000001	1.15294055849414
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.011764700000000001	1.15294055849414
HEMOPHILIA A WITH VASCULAR ABNORMALITY	0.011764700000000001	1.15294055849414
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.011764700000000001	1.15294055849414
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.011764700000000001	1.15294055849414
THROMBOCYTOPENIA 5; THC5	0.011764700000000001	1.15294055849414
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.011764700000000001	1.15294055849414
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.011764700000000001	1.15294055849414
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.011764700000000001	1.15294055849414
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.011764700000000001	1.15294055849414
PURPURA SIMPLEX	0.011764700000000001	1.15294055849414
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.011764700000000001	1.15294055849414
THROMBOCYTOPENIA 2	0.011764700000000001	1.15294055849414
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.011764700000000001	1.15294055849414
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.011764700000000001	1.15294055849414
BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	0.011764700000000001	1.15294055849414
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.011764700000000001	1.15294055849414
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.011764700000000001	1.15294055849414
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.011764700000000001	1.15294055849414
PLASMIN INHIBITOR DEFICIENCY	0.011764700000000001	1.15294055849414
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.011764700000000001	1.15294055849414
BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	0.011764700000000001	1.15294055849414
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.011764700000000001	1.15294055849414
FANCONI ANEMIA	0.011764700000000001	1.15294055849414
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.011764700000000001	1.15294055849414
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.011764700000000001	1.15294055849414
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.011764700000000001	1.15294055849414
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.011764700000000001	1.15294055849414
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.011764700000000001	1.15294055849414
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.011764700000000001	1.15294055849414
EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTINABNORMALITY	0.011764700000000001	1.15294055849414
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.011764700000000001	1.15294055849414
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.011764700000000001	1.15294055849414
#614009 BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13;;BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANEA2 RECEPTOR	0.011764700000000001	1.15294055849414
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.011764700000000001	1.15294055849414
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.011764700000000001	1.15294055849414
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.011764700000000001	1.15294055849414
EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	0.011764700000000001	1.15294055849414
176630 PRIMARY RELEASE DISORDER OF PLATELETS	0.011764700000000001	1.15294055849414
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.011764700000000001	1.15294055849414
FACTOR V DEFICIENCY	0.011764700000000001	1.15294055849414
%605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12;;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;;PGHS1 DEFICIENCY;;PLATELET CYCLOOXYGENASE 1 DEFICIENCY;;PLATELET COX1 DEFICIENCY	0.011764700000000001	1.15294055849414
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.011363600000000001	1.1136327599092206
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.011363600000000001	1.1136327599092206
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.011363600000000001	1.1136327599092206
3MC SYNDROME 2	0.011363600000000001	1.1136327599092206
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.011363600000000001	1.1136327599092206
#608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	0.011363600000000001	1.1136327599092206
WARBURG MICRO SYNDROME 1	0.011363600000000001	1.1136327599092206
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.011363600000000001	1.1136327599092206
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.011363600000000001	1.1136327599092206
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.011363600000000001	1.1136327599092206
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.011363600000000001	1.1136327599092206
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.011363600000000001	1.1136327599092206
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.011363600000000001	1.1136327599092206
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.011363600000000001	1.1136327599092206
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.011363600000000001	1.1136327599092206
WILSON DISEASE	0.011363600000000001	1.1136327599092206
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.011363600000000001	1.1136327599092206
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.011363600000000001	1.1136327599092206
NEMALINE MYOPATHY 7; NEM7	0.011363600000000001	1.1136327599092206
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011363600000000001	1.1136327599092206
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.011363600000000001	1.1136327599092206
MEESTER-LOEYS SYNDROME; MRLS	0.011363600000000001	1.1136327599092206
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.011363600000000001	1.1136327599092206
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.011363600000000001	1.1136327599092206
HOLOPROSENCEPHALY 2; HPE2	0.011054221	1.0833136190007095
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.011054221	1.0833136190007095
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.011054221	1.0833136190007095
CODAS SYNDROME	0.011054221	1.0833136190007095
KAPUR-TORIELLO SYNDROME	0.011054221	1.0833136190007095
POTOCKI-LUPSKI SYNDROME	0.011054221	1.0833136190007095
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.011054221	1.0833136190007095
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.011054221	1.0833136190007095
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.011046901000000001	1.0825962590265348
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.011046901000000001	1.0825962590265348
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.011046901000000001	1.0825962590265348
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.011046901000000001	1.0825962590265348
LYMPHEDEMA, HEREDITARY, III	0.01013847	0.993570024231479
CRANIOLENTICULOSUTURAL DYSPLASIA	0.01013847	0.993570024231479
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.01013847	0.993570024231479
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.01013847	0.993570024231479
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01013847	0.993570024231479
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01013847	0.993570024231479
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.01013847	0.993570024231479
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.01013847	0.993570024231479
HAREL-YOON SYNDROME; HAYOS	0.01013115	0.992852664257304
AUTISM, SUSCEPTIBILITY TO, 18	0.009112470999999999	0.8930221258512033
WEBB-DATTANI SYNDROME; WEDAS	0.009112470999999999	0.8930221258512033
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.009112470999999999	0.8930221258512033
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.009112470999999999	0.8930221258512033
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.009112470999999999	0.8930221258512033
MOWAT-WILSON SYNDROME; MOWS	0.009112470999999999	0.8930221258512033
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.009112470999999999	0.8930221258512033
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.009112470999999999	0.8930221258512033
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.009112470999999999	0.8930221258512033
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.009112470999999999	0.8930221258512033
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.009112470999999999	0.8930221258512033
KLEEFSTRA SYNDROME	0.009112470999999999	0.8930221258512033
WIEDEMANN-STEINER SYNDROME; WDSTS	0.009112470999999999	0.8930221258512033
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.009112470999999999	0.8930221258512033
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.009112470999999999	0.8930221258512033
HYPOPHOSPHATASIA, INFANTILE	0.009112470999999999	0.8930221258512033
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.009112470999999999	0.8930221258512033
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.009112470999999999	0.8930221258512033
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.009112470999999999	0.8930221258512033
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.009112470999999999	0.8930221258512033
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.009112470999999999	0.8930221258512033
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.009112470999999999	0.8930221258512033
Glycosylphosphatidylinositol biosynthesis defect 18	0.009112470999999999	0.8930221258512033
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.009112470999999999	0.8930221258512033
HEART AND BRAIN MALFORMATION SYNDROME	0.009112470999999999	0.8930221258512033
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.009105151	0.8923047658770284
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00819672	0.8032785310819728
TURNPENNY-FRY SYNDROME; TPFS	0.00819672	0.8032785310819728
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.8032785310819728
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00819672	0.8032785310819728
#614266 BARRETT ESOPHAGUS;;BARRETT METAPLASIAADENOCARCINOMA OF ESOPHAGUS, INCLUDED	0.00819672	0.8032785310819728
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00819672	0.8032785310819728
GASTROESOPHAGEAL REFLUX	0.00819672	0.8032785310819728
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.8032785310819728
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.00819672	0.8032785310819728
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00819672	0.8032785310819728
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	0.8032785310819728
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	0.8032785310819728
ANAL SPHINCTER DYSPLASIA; ASDP	0.00819672	0.8032785310819728
VISCERAL MYOPATHY; VSCM	0.00819672	0.8032785310819728
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00819672	0.8032785310819728
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.8032785310819728
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00819672	0.8032785310819728
MEIER-GORLIN SYNDROME 1; MGORS1	0.00819672	0.8032785310819728
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00819672	0.8032785310819728
SWEENEY-COX SYNDROME; SWCOS	0.00819672	0.8032785310819728
300270 ADRENOMYODYSTROPHY	0.00819672	0.8032785310819728
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00819672	0.8032785310819728
PORPHYRIA VARIEGATA	0.00819672	0.8032785310819728
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.8032785310819728
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00819672	0.8032785310819728
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	0.8032785310819728
TOWNES-BROCKS SYNDROME 1; TBS1	0.00819672	0.8032785310819728
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	0.8032785310819728
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00819672	0.8032785310819728
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00819672	0.8032785310819728
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	0.8032785310819728
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00819672	0.8032785310819728
FG SYNDROME 2; FGS2	0.00819672	0.8032785310819728
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	0.8032785310819728
NIEMANN-PICK DISEASE, TYPE A	0.00819672	0.8032785310819728
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00819672	0.8032785310819728
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00819672	0.8032785310819728
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00819672	0.8032785310819728
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	0.8032785310819728
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00819672	0.8032785310819728
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.8032785310819728
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.8032785310819728
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	0.8032785310819728
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00819672	0.8032785310819728
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00819672	0.8032785310819728
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0081894	0.8025611711077978
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0081894	0.8025611711077978
ZIMMERMANN-LABAND SYNDROME 1	0.007423711	0.7275236518091485
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.007423711	0.7275236518091485
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.007423711	0.7275236518091485
COWDEN SYNDROME 6; CWS6	0.007423711	0.7275236518091485
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.007423711	0.7275236518091485
COFFIN-SIRIS SYNDROME 1; CSS1	0.007423711	0.7275236518091485
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.007423711	0.7275236518091485
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.007423711	0.7275236518091485
CHROMOSOME 16p13.3 DELETION SYNDROME	0.007423711	0.7275236518091485
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.007423711	0.7275236518091485
PETERS-PLUS SYNDROME; PTRPLS	0.007423711	0.7275236518091485
PRADER-WILLI SYNDROME; PWS	0.007423711	0.7275236518091485
COWDEN SYNDROME 5; CWS5	0.007423711	0.7275236518091485
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.007423711	0.7275236518091485
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.007423711	0.7275236518091485
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.007423711	0.7275236518091485
BRITTLE CORNEA SYNDROME	0.00650796	0.6377800570399179
COHEN-GIBSON SYNDROME; COGIS	0.00650796	0.6377800570399179
CHROMOSOME 9P DELETION SYNDROME	0.00650796	0.6377800570399179
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00650796	0.6377800570399179
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00650796	0.6377800570399179
LAMB-SHAFFER SYNDROME	0.00650796	0.6377800570399179
HUNTER-MACDONALD SYNDROME	0.00650796	0.6377800570399179
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00650796	0.6377800570399179
DESBUQUOIS DYSPLASIA 1	0.00650796	0.6377800570399179
STICKLER SYNDROME, TYPE I	0.00650796	0.6377800570399179
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00650796	0.6377800570399179
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00650796	0.6377800570399179
MARFANOID HABITUS WITH SITUS INVERSUS	0.00650796	0.6377800570399179
MUCOLIPIDOSIS III GAMMA	0.00650796	0.6377800570399179
MEIER-GORLIN SYNDROME 7	0.00650796	0.6377800570399179
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.006480691	0.6351076951361229
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.006480691	0.6351076951361229
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.006480691	0.6351076951361229
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.006480691	0.6351076951361229
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.006480691	0.6351076951361229
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.006480691	0.6351076951361229
WIEACKER-WOLFF SYNDROME	0.006480691	0.6351076951361229
Pierpont syndrome	0.006480691	0.6351076951361229
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.006480691	0.6351076951361229
COFFIN-SIRIS SYNDROME 4; CSS4	0.006480691	0.6351076951361229
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.006480691	0.6351076951361229
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.006480691	0.6351076951361229
COFFIN-SIRIS SYNDROME 3; CSS3	0.006480691	0.6351076951361229
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.006480691	0.6351076951361229
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.006480691	0.6351076951361229
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.006480691	0.6351076951361229
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.006480691	0.6351076951361229
Mulchandani-Bhoj-Conlin syndrome	0.00556494	0.5453641003668923
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00556494	0.5453641003668923
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00556494	0.5453641003668923
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00556494	0.5453641003668923
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00556494	0.5453641003668923
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00556494	0.5453641003668923
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00556494	0.5453641003668923
CHARGE SYNDROME	0.00556494	0.5453641003668923
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00556494	0.5453641003668923
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00556494	0.5453641003668923
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00556494	0.5453641003668923
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00556494	0.5453641003668923
NEMALINE MYOPATHY 2; NEM2	0.00556494	0.5453641003668923
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00556494	0.5453641003668923
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00556494	0.5453641003668923
STUVE-WIEDEMANN SYNDROME	0.00556494	0.5453641003668923
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0054819610000000005	0.5372321586596422
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.0054819610000000005	0.5372321586596422
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0054819610000000005	0.5372321586596422
FLYNN-AIRD SYNDROME	0.0054819610000000005	0.5372321586596422
MEHMO SYNDROME; MEHMO	0.0054819610000000005	0.5372321586596422
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0054819610000000005	0.5372321586596422
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0054819610000000005	0.5372321586596422
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0054819610000000005	0.5372321586596422
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0054819610000000005	0.5372321586596422
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0054819610000000005	0.5372321586596422
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.0054819610000000005	0.5372321586596422
TEMTAMY SYNDROME; TEMTYS	0.0054819610000000005	0.5372321586596422
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.0054819610000000005	0.5372321586596422
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0054819610000000005	0.5372321586596422
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0054819610000000005	0.5372321586596422
ALAND ISLAND EYE DISEASE	0.00456621	0.4474885638904117
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00456621	0.4474885638904117
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.00456621	0.4474885638904117
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00456621	0.4474885638904117
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00456621	0.4474885638904117
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00456621	0.4474885638904117
%310460 MYOPIA 1, X-LINKED; MYP1	0.00456621	0.4474885638904117
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00456621	0.4474885638904117
%609257 MYOPIA 8; MYP8	0.00456621	0.4474885638904117
OPTIC ATROPHY 11; OPA11	0.00456621	0.4474885638904117
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00456621	0.4474885638904117
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00456621	0.4474885638904117
MYOPIA 15; MYP15	0.00456621	0.4474885638904117
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00456621	0.4474885638904117
#156550 KNIEST DYSPLASIA	0.00456621	0.4474885638904117
#312600 RETINITIS PIGMENTOSA 2; RP2	0.00456621	0.4474885638904117
RETINITIS PIGMENTOSA 75; RP75	0.00456621	0.4474885638904117
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00456621	0.4474885638904117
#608908 MYOPIA 6; MYP6	0.00456621	0.4474885638904117
#257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B;;NIGHT BLINDNESS, CONGENITAL STATIONARY, COMPLETE, AUTOSOMAL RECESSIVE;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00456621	0.4474885638904117
#154780 MARSHALL SYNDROME; MRSHS	0.00456621	0.4474885638904117
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00456621	0.4474885638904117
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00456621	0.4474885638904117
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00456621	0.4474885638904117
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00456621	0.4474885638904117
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00456621	0.4474885638904117
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00456621	0.4474885638904117
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00456621	0.4474885638904117
%609256 MYOPIA 7; MYP7	0.00456621	0.4474885638904117
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.00456621	0.4474885638904117
ALAGILLE SYNDROME 1; ALGS1	0.00456621	0.4474885638904117
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00456621	0.4474885638904117
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00456621	0.4474885638904117
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00456621	0.4474885638904117
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.00456621	0.4474885638904117
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00456621	0.4474885638904117
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00456621	0.4474885638904117
%609258 MYOPIA 9; MYP9	0.00456621	0.4474885638904117
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00456621	0.4474885638904117
#609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR;;STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;;STICKLER SYNDROME, ATYPICALRHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD,INCLUDED	0.00456621	0.4474885638904117
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00456621	0.4474885638904117
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00456621	0.4474885638904117
FRONTOOCULAR SYNDROME	0.00456621	0.4474885638904117
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00456621	0.4474885638904117
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00456621	0.4474885638904117
RETINAL CONE DYSTROPHY 3B	0.00456621	0.4474885638904117
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00456621	0.4474885638904117
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00456621	0.4474885638904117
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00456621	0.4474885638904117
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00456621	0.4474885638904117
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00456621	0.4474885638904117
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00456621	0.4474885638904117
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00456621	0.4474885638904117
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00456621	0.4474885638904117
WEILL-MARCHESANI SYNDROME 3	0.00456621	0.4474885638904117
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00456621	0.4474885638904117
MICROSPHEROPHAKIA WITH HERNIA	0.00456621	0.4474885638904117
NOONAN SYNDROME 6; NS6	0.00456621	0.4474885638904117
MYOPIA, INFANTILE SEVERE	0.00456621	0.4474885638904117
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00456621	0.4474885638904117
GLAUCOMA, PRIMARY OPEN ANGLE	0.00456621	0.4474885638904117
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00456621	0.4474885638904117
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00456621	0.4474885638904117
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00456621	0.4474885638904117
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00456621	0.4474885638904117
GLAUCOMA 1, OPEN ANGLE, A	0.00456621	0.4474885638904117
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.00456621	0.4474885638904117
BARDET-BIEDL SYNDROME 21; BBS21	0.00456621	0.4474885638904117
HYPERTRYPTOPHANEMIA; HYPTRP	0.00456621	0.4474885638904117
GASTROCUTANEOUS SYNDROME	0.00456621	0.4474885638904117
#615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	0.00456621	0.4474885638904117
BARDET-BIEDL SYNDROME 1; BBS1	0.00456621	0.4474885638904117
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00456621	0.4474885638904117
VAN BOGAERT-HOZAY SYNDROME	0.00456621	0.4474885638904117
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00456621	0.4474885638904117
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00456621	0.4474885638904117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00456621	0.4474885638904117
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00456621	0.4474885638904117
ALPORT SYNDROME, X-LINKED; ATS	0.00456621	0.4474885638904117
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00456621	0.4474885638904117
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00456621	0.4474885638904117
%609259 MYOPIA 10; MYP10	0.00456621	0.4474885638904117
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00456621	0.4474885638904117
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00456621	0.4474885638904117
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00456621	0.4474885638904117
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00456621	0.4474885638904117
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.00456621	0.4474885638904117
RETINITIS PIGMENTOSA 1	0.00456621	0.4474885638904117
#310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A;;CSNB, COMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA;;HEMERALOPIA-MYOPIA;;MYOPIA-NIGHT BLINDNESS; NBM1NYCTALOPIA, INCLUDED	0.00456621	0.4474885638904117
SVEINSSON CHORIORETINAL ATROPHY	0.00456621	0.4474885638904117
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00456621	0.4474885638904117
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00456621	0.4474885638904117
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00456621	0.4474885638904117
#115900 CATARACT 42; CTRCT42	0.00456621	0.4474885638904117
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00456621	0.4474885638904117
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00456621	0.4474885638904117
CRANIOECTODERMAL DYSPLASIA 1	0.00456621	0.4474885638904117
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00456621	0.4474885638904117
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00456621	0.4474885638904117
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00456621	0.4474885638904117
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00456621	0.4474885638904117
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00456621	0.4474885638904117
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00456621	0.4474885638904117
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00456621	0.4474885638904117
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00456621	0.4474885638904117
HYPEREKPLEXIA 2; HKPX2	0.00456621	0.4474885638904117
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00456621	0.4474885638904117
Contractural arachnodactyly, congenital	0.00456621	0.4474885638904117
MICROCORIA, CONGENITAL	0.00456621	0.4474885638904117
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00456621	0.4474885638904117
BLUE CONE MONOCHROMACY; BCM	0.00456621	0.4474885638904117
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00456621	0.4474885638904117
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.004538941	0.4448162019866167
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.004538941	0.4448162019866167
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.004538941	0.4448162019866167
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004538941	0.4448162019866167
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.004538941	0.4448162019866167
COFFIN-SIRIS SYNDROME 2; CSS2	0.004538941	0.4448162019866167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.004538941	0.4448162019866167
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.004538941	0.4448162019866167
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.004538941	0.4448162019866167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.004538941	0.4448162019866167
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004538941	0.4448162019866167
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004538941	0.4448162019866167
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004538941	0.4448162019866167
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.004538941	0.4448162019866167
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.004538941	0.4448162019866167
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004538941	0.4448162019866167
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.004538941	0.4448162019866167
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.004538941	0.4448162019866167
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004538941	0.4448162019866167
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.004538941	0.4448162019866167
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.004538941	0.4448162019866167
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004538941	0.4448162019866167
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.004538941	0.4448162019866167
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.004538941	0.4448162019866167
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.004538941	0.4448162019866167
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.004538941	0.4448162019866167
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.004538941	0.4448162019866167
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.004538941	0.4448162019866167
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004538941	0.4448162019866167
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004538941	0.4448162019866167
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.004538941	0.4448162019866167
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004538941	0.4448162019866167
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.004538941	0.4448162019866167
COFFIN-SIRIS SYNDROME 5	0.004538941	0.4448162019866167
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.004538941	0.4448162019866167
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004538941	0.4448162019866167
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004538941	0.4448162019866167
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004538941	0.4448162019866167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.004538941	0.4448162019866167
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.004538941	0.4448162019866167
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004538941	0.4448162019866167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004538941	0.4448162019866167
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.004538941	0.4448162019866167
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004538941	0.4448162019866167
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.004538941	0.4448162019866167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.004538941	0.4448162019866167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.004538941	0.4448162019866167
AICARDI-GOUTIERES SYNDROME 7	0.004538941	0.4448162019866167
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.004538941	0.4448162019866167
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004538941	0.4448162019866167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.004538941	0.4448162019866167
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004538941	0.4448162019866167
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.004538941	0.4448162019866167
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004538941	0.4448162019866167
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.004538941	0.4448162019866167
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004538941	0.4448162019866167
SMITH-KINGSMORE SYNDROME; SKS	0.004538941	0.4448162019866167
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.004538941	0.4448162019866167
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.004538941	0.4448162019866167
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.004538941	0.4448162019866167
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004538941	0.4448162019866167
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.004538941	0.4448162019866167
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004538941	0.4448162019866167
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004538941	0.4448162019866167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.004538941	0.4448162019866167
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004538941	0.4448162019866167
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.004538941	0.4448162019866167
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004538941	0.4448162019866167
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.004538941	0.4448162019866167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.004538941	0.4448162019866167
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004538941	0.4448162019866167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004538941	0.4448162019866167
RETINITIS PIGMENTOSA 59; RP59	0.004538941	0.4448162019866167
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004538941	0.4448162019866167
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.004538941	0.4448162019866167
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.004538941	0.4448162019866167
Helsmoortel-van der Aa syndrome	0.004538941	0.4448162019866167
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.004538941	0.4448162019866167
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00362319	0.3550726072173861
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00362319	0.3550726072173861
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00362319	0.3550726072173861
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00362319	0.3550726072173861
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00362319	0.3550726072173861
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00362319	0.3550726072173861
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00362319	0.3550726072173861
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00362319	0.3550726072173861
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00362319	0.3550726072173861
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00362319	0.3550726072173861
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00362319	0.3550726072173861
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00362319	0.3550726072173861
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00362319	0.3550726072173861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00362319	0.3550726072173861
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00362319	0.3550726072173861
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00362319	0.3550726072173861
PEHO-LIKE SYNDROME; PEHOL	0.00362319	0.3550726072173861
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.00362319	0.3550726072173861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00362319	0.3550726072173861
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.00362319	0.3550726072173861
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00362319	0.3550726072173861
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00362319	0.3550726072173861
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00362319	0.3550726072173861
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00362319	0.3550726072173861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00362319	0.3550726072173861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00362319	0.3550726072173861
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00362319	0.3550726072173861
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00362319	0.3550726072173861
Mental retardation, autosomal dominant 21	0.00362319	0.3550726072173861
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00362319	0.3550726072173861
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.00362319	0.3550726072173861
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00362319	0.3550726072173861
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00362319	0.3550726072173861
Retinitis pigmentosa with or without skeletal anomalies	0.00362319	0.3550726072173861
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00362319	0.3550726072173861
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00362319	0.3550726072173861
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00362319	0.3550726072173861
#168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC;;PARALYSIS PERIODICA PARAMYOTONICAPARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED	0.00362319	0.3550726072173861
COMBINED SAPOSIN DEFICIENCY	0.00362319	0.3550726072173861
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00362319	0.3550726072173861
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00362319	0.3550726072173861
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00362319	0.3550726072173861
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00362319	0.3550726072173861
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00362319	0.3550726072173861
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00362319	0.3550726072173861
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00362319	0.3550726072173861
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00362319	0.3550726072173861
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00362319	0.3550726072173861
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00362319	0.3550726072173861
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00362319	0.3550726072173861
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00362319	0.3550726072173861
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.00362319	0.3550726072173861
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00362319	0.3550726072173861
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00362319	0.3550726072173861
CHIARI MALFORMATION TYPE II	0.00362319	0.3550726072173861
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00362319	0.3550726072173861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00362319	0.3550726072173861
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.00362319	0.3550726072173861
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002857501	0.2800350879187368
DIGEORGE SYNDROME; DGS	0.002857501	0.2800350879187368
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.002857501	0.2800350879187368
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002857501	0.2800350879187368
COFFIN-LOWRY SYNDROME; CLS	0.002857501	0.2800350879187368
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002857501	0.2800350879187368
CLARK-BARAITSER SYNDROME	0.002857501	0.2800350879187368
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.002857501	0.2800350879187368
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.002857501	0.2800350879187368
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002857501	0.2800350879187368
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002857501	0.2800350879187368
WITTEVEEN-KOLK SYNDROME	0.002857501	0.2800350879187368
CHROMOSOME 18Q DELETION SYNDROME	0.002857501	0.2800350879187368
SECKEL SYNDROME 1; SCKL1	0.002857501	0.2800350879187368
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.002857501	0.2800350879187368
KLEEFSTRA SYNDROME 2; KLEFS2	0.002857501	0.2800350879187368
RENPENNING SYNDROME 1; RENS1	0.002857501	0.2800350879187368
MENTAL RETARDATION, X-LINKED 102	0.002857501	0.2800350879187368
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.002857501	0.2800350879187368
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.002857501	0.2800350879187368
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.002857501	0.2800350879187368
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.002857501	0.2800350879187368
ASPARTYLGLUCOSAMINURIA; AGU	0.002857501	0.2800350879187368
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.002857501	0.2800350879187368
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002857501	0.2800350879187368
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.002857501	0.2800350879187368
FRAGILE X MENTAL RETARDATION SYNDROME	0.002857501	0.2800350879187368
SHASHI-PENA SYNDROME; SHAPNS	0.002857501	0.2800350879187368
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002857501	0.2800350879187368
RAYNAUD-CLAES SYNDROME; MRXSRC	0.002857501	0.2800350879187368
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.002857501	0.2800350879187368
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.002857501	0.2800350879187368
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002857501	0.2800350879187368
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.002857501	0.2800350879187368
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.002857501	0.2800350879187368
NEUROFIBROMATOSIS, TYPE I	0.002857501	0.2800350879187368
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.002857501	0.2800350879187368
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.002857501	0.2800350879187368
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.002857501	0.2800350879187368
RAMON SYNDROME	0.002857501	0.2800350879187368
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.002857501	0.2800350879187368
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.002857501	0.2800350879187368
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.002857501	0.2800350879187368
ATKIN-FLAITZ SYNDROME	0.002857501	0.2800350879187368
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002857501	0.2800350879187368
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.002857501	0.2800350879187368
PETTIGREW SYNDROME	0.002857501	0.2800350879187368
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.002857501	0.2800350879187368
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002857501	0.2800350879187368
MENTAL RETARDATION, X-LINKED 82	0.002857501	0.2800350879187368
RECOMBINANT CHROMOSOME 8 SYNDROME	0.002857501	0.2800350879187368
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002857501	0.2800350879187368
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.002857501	0.2800350879187368
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.002857501	0.2800350879187368
MARDEN-WALKER SYNDROME	0.002857501	0.2800350879187368
C SYNDROME	0.002857501	0.2800350879187368
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002857501	0.2800350879187368
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.002857501	0.2800350879187368
WEAVER SYNDROME	0.002857501	0.2800350879187368
#259450 BRUCK SYNDROME 1; BRKS1	0.00194175	0.19029149314950622
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00194175	0.19029149314950622
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.00194175	0.19029149314950622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00194175	0.19029149314950622
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.00194175	0.19029149314950622
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00194175	0.19029149314950622
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00194175	0.19029149314950622
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00194175	0.19029149314950622
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00194175	0.19029149314950622
FOCAL DERMAL HYPOPLASIA; FDH	0.00194175	0.19029149314950622
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.00194175	0.19029149314950622
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00194175	0.19029149314950622
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.00194175	0.19029149314950622
NEMALINE MYOPATHY 1; NEM1	0.00194175	0.19029149314950622
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00194175	0.19029149314950622
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.00194175	0.19029149314950622
CEREBELLOFACIODENTAL SYNDROME	0.00194175	0.19029149314950622
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00194175	0.19029149314950622
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00194175	0.19029149314950622
Aarskog-Scott syndrome	0.00194175	0.19029149314950622
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.00194175	0.19029149314950622
LERI-WEILL DYSCHONDROSTEOSIS	0.00194175	0.19029149314950622
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00194175	0.19029149314950622
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00194175	0.19029149314950622
OSTEOGENESIS IMPERFECTA, TYPE X	0.00194175	0.19029149314950622
SPONDYLOCAMPTODACTYLY	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.00194175	0.19029149314950622
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00194175	0.19029149314950622
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00194175	0.19029149314950622
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00194175	0.19029149314950622
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00194175	0.19029149314950622
XFE PROGEROID SYNDROME; XFEPS	0.00194175	0.19029149314950622
NAIL-PATELLA SYNDROME	0.00194175	0.19029149314950622
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00194175	0.19029149314950622
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.00194175	0.19029149314950622
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00194175	0.19029149314950622
FACIOCARDIORENAL SYNDROME	0.00194175	0.19029149314950622
#615731 NEMALINE MYOPATHY 9; NEM9	0.00194175	0.19029149314950622
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00194175	0.19029149314950622
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00194175	0.19029149314950622
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.00194175	0.19029149314950622
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.00194175	0.19029149314950622
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00194175	0.19029149314950622
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00194175	0.19029149314950622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00194175	0.19029149314950622
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00194175	0.19029149314950622
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00194175	0.19029149314950622
IVIC SYNDROME	0.00194175	0.19029149314950622
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00194175	0.19029149314950622
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00194175	0.19029149314950622
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00194175	0.19029149314950622
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00194175	0.19029149314950622
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.00194175	0.19029149314950622
THORACOLARYNGOPELVIC DYSPLASIA	0.00194175	0.19029149314950622
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00194175	0.19029149314950622
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.00194175	0.19029149314950622
MYOPATHY, SCAPULOHUMEROPERONEAL	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00194175	0.19029149314950622
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00194175	0.19029149314950622
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00194175	0.19029149314950622
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00194175	0.19029149314950622
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00194175	0.19029149314950622
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00194175	0.19029149314950622
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00194175	0.19029149314950622
#614434 CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2	0.00194175	0.19029149314950622
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00194175	0.19029149314950622
TIBIAL TORSION, BILATERAL MEDIAL	0.00194175	0.19029149314950622
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00194175	0.19029149314950622
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.00194175	0.19029149314950622
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00194175	0.19029149314950622
SPRENGEL DEFORMITY	0.00194175	0.19029149314950622
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00194175	0.19029149314950622
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00194175	0.19029149314950622
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00194175	0.19029149314950622
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00194175	0.19029149314950622
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00194175	0.19029149314950622
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00194175	0.19029149314950622
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00194175	0.19029149314950622
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.00194175	0.19029149314950622
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00194175	0.19029149314950622
SALIH MYOPATHY; SALMY	0.00194175	0.19029149314950622
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00194175	0.19029149314950622
MYOPATHY, DISTAL, 1; MPD1	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00194175	0.19029149314950622
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00194175	0.19029149314950622
MUCOLIPIDOSIS III ALPHA/BETA	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00194175	0.19029149314950622
NEU-LAXOVA SYNDROME 2; NLS2	0.00194175	0.19029149314950622
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00194175	0.19029149314950622
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00194175	0.19029149314950622
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.00194175	0.19029149314950622
MYOCLONIC-ATONIC EPILEPSY	0.00194175	0.19029149314950622
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00194175	0.19029149314950622
PYCNODYSOSTOSIS	0.00194175	0.19029149314950622
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00194175	0.19029149314950622
#150250 LARSEN SYNDROME; LRS	0.00194175	0.19029149314950622
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00194175	0.19029149314950622
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.00194175	0.19029149314950622
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00194175	0.19029149314950622
SHPRINTZEN OMPHALOCELE SYNDROME	0.00194175	0.19029149314950622
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00194175	0.19029149314950622
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00194175	0.19029149314950622
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00194175	0.19029149314950622
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00194175	0.19029149314950622
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.00194175	0.19029149314950622
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00194175	0.19029149314950622
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00194175	0.19029149314950622
STEEL SYNDROME; STLS	0.00194175	0.19029149314950622
PSEUDODIASTROPHIC DYSPLASIA	0.00194175	0.19029149314950622
SYRINGOMYELIA, ISOLATED	0.00194175	0.19029149314950622
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00194175	0.19029149314950622
RUVALCABA SYNDROME	0.00194175	0.19029149314950622
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00194175	0.19029149314950622
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00194175	0.19029149314950622
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00194175	0.19029149314950622
PYLE DISEASE; PYL	0.00194175	0.19029149314950622
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00194175	0.19029149314950622
ALLAN-HERNDON-DUDLEY SYNDROME	0.00194175	0.19029149314950622
CLEIDOCRANIAL DYSPLASIA; CCD	0.00194175	0.19029149314950622
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00194175	0.19029149314950622
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00194175	0.19029149314950622
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00194175	0.19029149314950622
JOUBERT SYNDROME 7	0.00194175	0.19029149314950622
FRONTOMETAPHYSEAL DYSPLASIA	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00194175	0.19029149314950622
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00194175	0.19029149314950622
OROFACIODIGITAL SYNDROME V; OFD5	0.00194175	0.19029149314950622
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00194175	0.19029149314950622
#168400 PARASTREMMATIC DWARFISM	0.00194175	0.19029149314950622
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00194175	0.19029149314950622
BASAL CELL NEVUS SYNDROME	0.00194175	0.19029149314950622
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00194175	0.19029149314950622
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00194175	0.19029149314950622
CRANIOSYNOSTOSIS 6; CRS6	0.00194175	0.19029149314950622
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00194175	0.19029149314950622
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00194175	0.19029149314950622
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00194175	0.19029149314950622
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00194175	0.19029149314950622
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00194175	0.19029149314950622
231970 GLUTEAL MUSCLES, ABSENCE OF	0.00194175	0.19029149314950622
OGDEN SYNDROME; OGDNS	0.00194175	0.19029149314950622
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00194175	0.19029149314950622
NOONAN SYNDROME 4; NS4	0.00194175	0.19029149314950622
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00194175	0.19029149314950622
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00194175	0.19029149314950622
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00194175	0.19029149314950622
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00194175	0.19029149314950622
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.00194175	0.19029149314950622
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00194175	0.19029149314950622
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00194175	0.19029149314950622
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.00194175	0.19029149314950622
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00194175	0.19029149314950622
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00194175	0.19029149314950622
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00194175	0.19029149314950622
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00194175	0.19029149314950622
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00194175	0.19029149314950622
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00194175	0.19029149314950622
BETA-UREIDOPROPIONASE DEFICIENCY	0.00194175	0.19029149314950622
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00194175	0.19029149314950622
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00194175	0.19029149314950622
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00194175	0.19029149314950622
ALAZAMI SYNDROME; ALAZS	0.00194175	0.19029149314950622
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00194175	0.19029149314950622
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00194175	0.19029149314950622
TOWNES-BROCKS SYNDROME 2; TBS2	0.00194175	0.19029149314950622
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00194175	0.19029149314950622
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00194175	0.19029149314950622
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00194175	0.19029149314950622
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00194175	0.19029149314950622
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.00194175	0.19029149314950622
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00194175	0.19029149314950622
CZECH DYSPLASIA, METATARSAL TYPE	0.00194175	0.19029149314950622
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.00194175	0.19029149314950622
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00194175	0.19029149314950622
MORQUIO SYNDROME A	0.00194175	0.19029149314950622
METATROPIC DYSPLASIA	0.00194175	0.19029149314950622
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00194175	0.19029149314950622
HURLER-SCHEIE SYNDROME	0.00194175	0.19029149314950622
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.00194175	0.19029149314950622
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00194175	0.19029149314950622
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00194175	0.19029149314950622
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00194175	0.19029149314950622
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00194175	0.19029149314950622
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00194175	0.19029149314950622
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00194175	0.19029149314950622
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00194175	0.19029149314950622
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00194175	0.19029149314950622
HEMIHYPERPLASIA, ISOLATED	0.00194175	0.19029149314950622
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00194175	0.19029149314950622
MARINESCO-SJOGREN SYNDROME; MSS	0.00194175	0.19029149314950622
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00194175	0.19029149314950622
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.00194175	0.19029149314950622
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.00194175	0.19029149314950622
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00194175	0.19029149314950622
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00194175	0.19029149314950622
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00194175	0.19029149314950622
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00194175	0.19029149314950622
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.00194175	0.19029149314950622
NEMALINE MYOPATHY 3; NEM3	0.00194175	0.19029149314950622
PSEUDOACHONDROPLASIA	0.00194175	0.19029149314950622
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00194175	0.19029149314950622
POSTERIOR COLUMN ATAXIA	0.00194175	0.19029149314950622
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00194175	0.19029149314950622
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00194175	0.19029149314950622
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00194175	0.19029149314950622
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00194175	0.19029149314950622
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.00194175	0.19029149314950622
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00194175	0.19029149314950622
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00194175	0.19029149314950622
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00194175	0.19029149314950622
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00194175	0.19029149314950622
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00194175	0.19029149314950622
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00194175	0.19029149314950622
Congenital disorder of glycosylation, type IIh	0.00194175	0.19029149314950622
DUANE-RADIAL RAY SYNDROME; DRRS	0.00194175	0.19029149314950622
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00194175	0.19029149314950622
#307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2;;CHROMOSOME Xq27.1 INTERCHROMOSOMAL INSERTION SYNDROME;;CGH;;HCG	0.00194175	0.19029149314950622
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00194175	0.19029149314950622
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00194175	0.19029149314950622
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00194175	0.19029149314950622
LEBER OPTIC ATROPHY AND DYSTONIA	0.00194175	0.19029149314950622
OPSISMODYSPLASIA; OPSMD	0.00194175	0.19029149314950622
SOTOS SYNDROME 2	0.00194175	0.19029149314950622
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00194175	0.19029149314950622
SPONDYLOCOSTAL DYSOSTOSIS 5	0.00194175	0.19029149314950622
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000915751	0.08974359476923058
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.08974359476923058
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000915751	0.08974359476923058
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000915751	0.08974359476923058
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.08974359476923058
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.08974359476923058
LEIGH SYNDROME; LS	0.000915751	0.08974359476923058
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000915751	0.08974359476923058
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.08974359476923058
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.08974359476923058
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000915751	0.08974359476923058
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.08974359476923058
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000915751	0.08974359476923058
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000915751	0.08974359476923058
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000915751	0.08974359476923058
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.08974359476923058
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.08974359476923058
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000915751	0.08974359476923058
LATHOSTEROLOSIS	0.000915751	0.08974359476923058
Wolf-Hirschhorn Syndrome	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.08974359476923058
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.000915751	0.08974359476923058
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.08974359476923058
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000915751	0.08974359476923058
XQ25 DUPLICATION SYNDROME	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000915751	0.08974359476923058
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.08974359476923058
OHDO SYNDROME	0.000915751	0.08974359476923058
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.08974359476923058
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000915751	0.08974359476923058
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.08974359476923058
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.08974359476923058
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.000915751	0.08974359476923058
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000915751	0.08974359476923058
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.08974359476923058
GABA-TRANSAMINASE DEFICIENCY	0.000915751	0.08974359476923058
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000915751	0.08974359476923058
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000915751	0.08974359476923058
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000915751	0.08974359476923058
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.08974359476923058
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000915751	0.08974359476923058
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.08974359476923058
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000915751	0.08974359476923058
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000915751	0.08974359476923058
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.08974359476923058
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.08974359476923058
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.08974359476923058
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.08974359476923058
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000915751	0.08974359476923058
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000915751	0.08974359476923058
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.08974359476923058
CROME SYNDROME	0.000915751	0.08974359476923058
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.08974359476923058
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.08974359476923058
GURRIERI SYNDROME	0.000915751	0.08974359476923058
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.08974359476923058
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000915751	0.08974359476923058
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.08974359476923058
IMMUNODEFICIENCY 49; IMD49	0.000915751	0.08974359476923058
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.08974359476923058
OCULOECTODERMAL SYNDROME; OES	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000915751	0.08974359476923058
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.08974359476923058
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000915751	0.08974359476923058
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.08974359476923058
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000915751	0.08974359476923058
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.08974359476923058
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000915751	0.08974359476923058
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000915751	0.08974359476923058
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000915751	0.08974359476923058
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000915751	0.08974359476923058
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.08974359476923058
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000915751	0.08974359476923058
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000915751	0.08974359476923058
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000915751	0.08974359476923058
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000915751	0.08974359476923058
CHROMOSOME 5Q12 DELETION SYNDROME	0.000915751	0.08974359476923058
KUFOR-RAKEB SYNDROME	0.000915751	0.08974359476923058
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000915751	0.08974359476923058
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000915751	0.08974359476923058
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000915751	0.08974359476923058
#602398 DESMOSTEROLOSIS	0.000915751	0.08974359476923058
PERRAULT SYNDROME 3	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 90	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.08974359476923058
CHROMOSOME 1p35 DELETION SYNDROME	0.000915751	0.08974359476923058
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.08974359476923058
OROFACIODIGITAL SYNDROME I; OFD1	0.000915751	0.08974359476923058
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.000915751	0.08974359476923058
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000915751	0.08974359476923058
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000915751	0.08974359476923058
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.08974359476923058
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.08974359476923058
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.08974359476923058
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 9	0.000915751	0.08974359476923058
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.08974359476923058
WAISMAN SYNDROME; WSMN	0.000915751	0.08974359476923058
JOUBERT SYNDROME 30; JBTS30	0.000915751	0.08974359476923058
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.08974359476923058
VICI SYNDROME; VICIS	0.000915751	0.08974359476923058
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.08974359476923058
CROUZON SYNDROME	0.000915751	0.08974359476923058
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000915751	0.08974359476923058
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.000915751	0.08974359476923058
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.08974359476923058
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000915751	0.08974359476923058
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.08974359476923058
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000915751	0.08974359476923058
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000915751	0.08974359476923058
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.08974359476923058
HYPEREKPLEXIA 4; HKPX4	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000915751	0.08974359476923058
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.08974359476923058
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.08974359476923058
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.08974359476923058
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000915751	0.08974359476923058
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.08974359476923058
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.08974359476923058
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000915751	0.08974359476923058
HOLOPROSENCEPHALY 7	0.000915751	0.08974359476923058
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000915751	0.08974359476923058
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000915751	0.08974359476923058
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.08974359476923058
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000915751	0.08974359476923058
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.08974359476923058
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.08974359476923058
TUBEROUS SCLEROSIS 2; TSC2	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000915751	0.08974359476923058
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.08974359476923058
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.08974359476923058
ADAMS-OLIVER SYNDROME 2; AOS2	0.000915751	0.08974359476923058
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.08974359476923058
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000915751	0.08974359476923058
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.08974359476923058
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.08974359476923058
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000915751	0.08974359476923058
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.08974359476923058
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.08974359476923058
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.08974359476923058
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000915751	0.08974359476923058
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.000915751	0.08974359476923058
Muenke syndrome	0.000915751	0.08974359476923058
IMMUNODEFICIENCY 47	0.000915751	0.08974359476923058
CATEL-MANZKE SYNDROME; CATMANS	0.000915751	0.08974359476923058
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.08974359476923058
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.08974359476923058
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000915751	0.08974359476923058
PELIZAEUS-MERZBACHER DISEASE	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000915751	0.08974359476923058
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.08974359476923058
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.08974359476923058
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000915751	0.08974359476923058
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.08974359476923058
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000915751	0.08974359476923058
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000915751	0.08974359476923058
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.000915751	0.08974359476923058
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000915751	0.08974359476923058
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000915751	0.08974359476923058
EPILEPSY-TELANGIECTASIA	0.000915751	0.08974359476923058
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000915751	0.08974359476923058
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.08974359476923058
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000915751	0.08974359476923058
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.08974359476923058
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000915751	0.08974359476923058
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.08974359476923058
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.08974359476923058
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.08974359476923058
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.08974359476923058
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000915751	0.08974359476923058
MEND SYNDROME; MEND	0.000915751	0.08974359476923058
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000915751	0.08974359476923058
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.08974359476923058
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.08974359476923058
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.08974359476923058
GRISCELLI SYNDROME, TYPE 1	0.000915751	0.08974359476923058
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.08974359476923058
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.08974359476923058
FOUNTAIN SYNDROME	0.000915751	0.08974359476923058
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000915751	0.08974359476923058
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.08974359476923058
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000915751	0.08974359476923058
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.08974359476923058
HOLOPROSENCEPHALY 1; HPE1	0.000915751	0.08974359476923058
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.08974359476923058
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000915751	0.08974359476923058
INCONTINENTIA PIGMENTI; IP	0.000915751	0.08974359476923058
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.08974359476923058
KRABBE DISEASE	0.000915751	0.08974359476923058
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.08974359476923058
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.08974359476923058
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000915751	0.08974359476923058
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.000915751	0.08974359476923058
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.000915751	0.08974359476923058
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.08974359476923058
HYPERPROLINEMIA, TYPE II	0.000915751	0.08974359476923058
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000915751	0.08974359476923058
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.08974359476923058
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000915751	0.08974359476923058
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000915751	0.08974359476923058
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000915751	0.08974359476923058
ACROCALLOSAL SYNDROME; ACLS	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.08974359476923058
THREONINEMIA	0.000915751	0.08974359476923058
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000915751	0.08974359476923058
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000915751	0.08974359476923058
THYROCEREBRORETINAL SYNDROME	0.000915751	0.08974359476923058
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000915751	0.08974359476923058
SALLA DISEASE	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000915751	0.08974359476923058
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000915751	0.08974359476923058
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.08974359476923058
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.08974359476923058
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000915751	0.08974359476923058
ELEJALDE DISEASE	0.000915751	0.08974359476923058
NIEMANN-PICK DISEASE, TYPE C2	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.08974359476923058
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.08974359476923058
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000915751	0.08974359476923058
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000915751	0.08974359476923058
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000915751	0.08974359476923058
EPILEPSY, READING	0.000915751	0.08974359476923058
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000915751	0.08974359476923058
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000915751	0.08974359476923058
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000915751	0.08974359476923058
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000915751	0.08974359476923058
HARTNUP DISORDER	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000915751	0.08974359476923058
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.08974359476923058
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.000915751	0.08974359476923058
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.08974359476923058
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000915751	0.08974359476923058
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.08974359476923058
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.08974359476923058
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.08974359476923058
ADAMS-OLIVER SYNDROME 1; AOS1	0.000915751	0.08974359476923058
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.08974359476923058
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.08974359476923058
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.08974359476923058
AL KAISSI SYNDROME; ALKAS	0.000915751	0.08974359476923058
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000915751	0.08974359476923058
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000915751	0.08974359476923058
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.000915751	0.08974359476923058
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000915751	0.08974359476923058
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000915751	0.08974359476923058
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.08974359476923058
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000915751	0.08974359476923058
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.08974359476923058
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000915751	0.08974359476923058
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000915751	0.08974359476923058
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000915751	0.08974359476923058
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000915751	0.08974359476923058
STURGE-WEBER SYNDROME	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.08974359476923058
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000915751	0.08974359476923058
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.08974359476923058
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.08974359476923058
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.08974359476923058
HHHH SYNDROME	0.000915751	0.08974359476923058
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000915751	0.08974359476923058
1p36 microdeletion syndrome	0.000915751	0.08974359476923058
2q33.1 deletion syndrome	0.000915751	0.08974359476923058
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000915751	0.08974359476923058
POTOCKI-SHAFFER SYNDROME	0.000915751	0.08974359476923058
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.08974359476923058
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.08974359476923058
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000915751	0.08974359476923058
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000915751	0.08974359476923058
PEHO SYNDROME; PEHO	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000915751	0.08974359476923058
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.08974359476923058
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.08974359476923058
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.08974359476923058
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.08974359476923058
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000915751	0.08974359476923058
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.08974359476923058
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000915751	0.08974359476923058
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.08974359476923058
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.08974359476923058
ALEXANDER DISEASE	0.000915751	0.08974359476923058
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.08974359476923058
NEURAMINIDASE DEFICIENCY	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.08974359476923058
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000915751	0.08974359476923058
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.08974359476923058
MACDERMOT-WINTER SYNDROME	0.000915751	0.08974359476923058
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000915751	0.08974359476923058
MENKES DISEASE	0.000915751	0.08974359476923058
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000915751	0.08974359476923058
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.08974359476923058
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.08974359476923058
HYPER-BETA-ALANINEMIA	0.000915751	0.08974359476923058
PYRUVATE CARBOXYLASE DEFICIENCY	0.000915751	0.08974359476923058
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.08974359476923058
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.000915751	0.08974359476923058
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.08974359476923058
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000915751	0.08974359476923058
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000915751	0.08974359476923058
Myhre syndrome	0.000915751	0.08974359476923058
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.08974359476923058
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000915751	0.08974359476923058
ADENYLOSUCCINASE DEFICIENCY	0.000915751	0.08974359476923058
CHROMOSOME 16p13.2 DELETION SYNDROME	0.000915751	0.08974359476923058
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000915751	0.08974359476923058
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000915751	0.08974359476923058
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.08974359476923058
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.08974359476923058
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000915751	0.08974359476923058
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000915751	0.08974359476923058
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.08974359476923058
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000915751	0.08974359476923058
HUNTINGTON DISEASE; HD	0.000915751	0.08974359476923058
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.08974359476923058
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.08974359476923058
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.08974359476923058
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.08974359476923058
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.08974359476923058
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000915751	0.08974359476923058
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.08974359476923058
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000915751	0.08974359476923058
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.08974359476923058
KIFAFA SEIZURE DISORDER	0.000915751	0.08974359476923058
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000915751	0.08974359476923058
ALZHEIMER DISEASE 3; AD	0.000915751	0.08974359476923058
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000915751	0.08974359476923058
LISSENCEPHALY 1; LIS1	0.000915751	0.08974359476923058
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000915751	0.08974359476923058
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.08974359476923058
BAND HETEROTOPIA; BH	0.000915751	0.08974359476923058
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000915751	0.08974359476923058
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.08974359476923058
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000915751	0.08974359476923058
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000915751	0.08974359476923058
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.08974359476923058
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000915751	0.08974359476923058
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000915751	0.08974359476923058
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.000915751	0.08974359476923058
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000915751	0.08974359476923058
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.08974359476923058
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.000915751	0.08974359476923058
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000915751	0.08974359476923058
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.000915751	0.08974359476923058
LANDAU-KLEFFNER SYNDROME	0.000915751	0.08974359476923058
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000915751	0.08974359476923058
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000915751	0.08974359476923058
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000915751	0.08974359476923058
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.08974359476923058
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.08974359476923058
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000915751	0.08974359476923058
SHUKLA-VERNON SYNDROME; SHUVER	0.000915751	0.08974359476923058
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.08974359476923058
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.08974359476923058
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000915751	0.08974359476923058
Cerebral creatine deficiency syndrome 2	0.000915751	0.08974359476923058
INFANTILE LIVER FAILURE SYNDROME 1	0.000915751	0.08974359476923058
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.08974359476923058
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000915751	0.08974359476923058
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.08974359476923058
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.08974359476923058
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000915751	0.08974359476923058
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000915751	0.08974359476923058
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.08974359476923058
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000915751	0.08974359476923058
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000915751	0.08974359476923058
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000915751	0.08974359476923058
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000915751	0.08974359476923058
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.08974359476923058
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000915751	0.08974359476923058
Angelman syndrome (Type 1)	0.000915751	0.08974359476923058
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000915751	0.08974359476923058
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000915751	0.08974359476923058
DARIER-WHITE DISEASE; DAR	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.08974359476923058
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000915751	0.08974359476923058
Adrenoleukodystrophy	0.000915751	0.08974359476923058
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.08974359476923058
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.08974359476923058
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.08974359476923058
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000915751	0.08974359476923058
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000915751	0.08974359476923058
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000915751	0.08974359476923058
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.08974359476923058
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.08974359476923058
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.08974359476923058
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.08974359476923058
PAPILLORENAL SYNDROME	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000915751	0.08974359476923058
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000915751	0.08974359476923058
LISSENCEPHALY 4	0.000915751	0.08974359476923058
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000915751	0.08974359476923058
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000915751	0.08974359476923058
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.08974359476923058
AUTISM	0.000915751	0.08974359476923058
FOLATE MALABSORPTION, HEREDITARY	0.000915751	0.08974359476923058
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.08974359476923058
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.08974359476923058
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.08974359476923058
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000915751	0.08974359476923058
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.08974359476923058
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.08974359476923058
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.08974359476923058
HYPERLYSINEMIA, TYPE I	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000915751	0.08974359476923058
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.08974359476923058
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000915751	0.08974359476923058
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000915751	0.08974359476923058
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.000915751	0.08974359476923058
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.08974359476923058
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 72	0.000915751	0.08974359476923058
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.08974359476923058
KBG SYNDROME	0.000915751	0.08974359476923058
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.08974359476923058
SCHINDLER DISEASE, TYPE I	0.000915751	0.08974359476923058
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.08974359476923058
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.08974359476923058
COACH SYNDROME	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 103	0.000915751	0.08974359476923058
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.08974359476923058
DYSOSTEOSCLEROSIS	0.000915751	0.08974359476923058
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000915751	0.08974359476923058
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.08974359476923058
PSEUDO-TORCH SYNDROME 2	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.08974359476923058
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000915751	0.08974359476923058
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000915751	0.08974359476923058
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.08974359476923058
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000915751	0.08974359476923058
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.08974359476923058
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000915751	0.08974359476923058
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000915751	0.08974359476923058
FILIPPI SYNDROME; FLPIS	0.000915751	0.08974359476923058
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000915751	0.08974359476923058
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.08974359476923058
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.000915751	0.08974359476923058
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.000915751	0.08974359476923058
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000915751	0.08974359476923058
CHROMOSOME 10Q26 DELETION SYNDROME	0.000915751	0.08974359476923058
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.08974359476923058
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000915751	0.08974359476923058
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.08974359476923058
GLASS SYNDROME	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000915751	0.08974359476923058
XYLOSIDASE DEFICIENCY	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.000915751	0.08974359476923058
15q13.3 microdeletion syndrome	0.000915751	0.08974359476923058
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000915751	0.08974359476923058
DIAMINOPENTANURIA	0.000915751	0.08974359476923058
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000915751	0.08974359476923058
ARGININOSUCCINIC ACIDURIA	0.000915751	0.08974359476923058
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000915751	0.08974359476923058
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.08974359476923058
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000915751	0.08974359476923058
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000915751	0.08974359476923058
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000915751	0.08974359476923058
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.08974359476923058
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000915751	0.08974359476923058
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000915751	0.08974359476923058
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.000915751	0.08974359476923058
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.08974359476923058
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000915751	0.08974359476923058
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.08974359476923058
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000915751	0.08974359476923058
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000915751	0.08974359476923058
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.08974359476923058
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000915751	0.08974359476923058
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.08974359476923058
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000915751	0.08974359476923058
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.08974359476923058
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.08974359476923058
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000915751	0.08974359476923058
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000915751	0.08974359476923058
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000915751	0.08974359476923058
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.08974359476923058
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000915751	0.08974359476923058
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000915751	0.08974359476923058
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.08974359476923058
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000915751	0.08974359476923058
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000915751	0.08974359476923058
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000915751	0.08974359476923058
GRACILE BONE DYSPLASIA; GCLEB	0.000915751	0.08974359476923058
KETOADIPICACIDURIA	0.000915751	0.08974359476923058
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.000915751	0.08974359476923058
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000915751	0.08974359476923058
LISSENCEPHALY 3; LIS3	0.000915751	0.08974359476923058
#614483 PORENCEPHALY 2; POREN2	0.000915751	0.08974359476923058
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000915751	0.08974359476923058
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000915751	0.08974359476923058
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000915751	0.08974359476923058
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.08974359476923058
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000915751	0.08974359476923058
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.08974359476923058
SECKEL SYNDROME 7; SCKL7	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.08974359476923058
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000915751	0.08974359476923058
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.08974359476923058
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000915751	0.08974359476923058
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.08974359476923058
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.08974359476923058
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.08974359476923058
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.08974359476923058
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000915751	0.08974359476923058
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.08974359476923058
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000915751	0.08974359476923058
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.08974359476923058
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.08974359476923058
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.08974359476923058
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.08974359476923058
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000915751	0.08974359476923058
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000915751	0.08974359476923058
MENTAL RETARDATION, X-LINKED 88	0.000915751	0.08974359476923058
LISSENCEPHALY 5; LIS5	0.000915751	0.08974359476923058
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.08974359476923058
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.08974359476923058
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.08974359476923058
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.08974359476923058
PALLISTER-HALL SYNDROME	0.000915751	0.08974359476923058
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.08974359476923058
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000915751	0.08974359476923058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000915751	0.08974359476923058
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.08974359476923058
KEUTEL SYNDROME; KTLS	0.000915751	0.08974359476923058
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.08974359476923058
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000915751	0.08974359476923058
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.08974359476923058
HYPERPROLINEMIA, TYPE I	0.000915751	0.08974359476923058
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.08974359476923058
LISSENCEPHALY 8; LIS8	0.000915751	0.08974359476923058
FRYNS SYNDROME; FRNS	0.000915751	0.08974359476923058
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000915751	0.08974359476923058
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.08974359476923058
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.08974359476923058
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000915751	0.08974359476923058
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.08974359476923058
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000915751	0.08974359476923058
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000915751	0.08974359476923058
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.08974359476923058
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.08974359476923058
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000915751	0.08974359476923058
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.08974359476923058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.08974359476923058
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.08974359476923058
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.08974359476923058
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000915751	0.08974359476923058
CITRULLINEMIA, CLASSIC	0.000915751	0.08974359476923058
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000915751	0.08974359476923058
Angelman syndrome (Type 2)	0.000915751	0.08974359476923058
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.08974359476923058
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.08974359476923058
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000915751	0.08974359476923058
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.08974359476923058
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.08974359476923058
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.08974359476923058
LUSCAN-LUMISH SYNDROME; LLS	0.000915751	0.08974359476923058
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.08974359476923058
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000915751	0.08974359476923058
